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ABSTRACT 
Tumor necrosis factor (TNF) is an important modulator of the innate immune system, 
responsible for the activation of immune cells as well as the removal of damaged cells. 
Aberrant TNF signalling can cause a number of pathologic conditions. TNF binding to 
TNF receptor 1 triggers the activation of nuclear factor kappa B (NF-κB) leading to pro-
inflammatory gene expression as well as the activation of the caspase cascade leading to 
death. In this study we observed that knockdown or knockout of the ubiquitin E3 ligase, 
Pellino3, sensitizes cells to TNF-induced apoptosis. Suppressed expression of Pellino3 
leads to the activation of NF-κB, thereby inducing the expression of a series of 
antiapoptotic proteins, indicating that the increased apoptosis that is observed in 
Pellino3-knockdown or –deficient cells is not due to the regulation of the NF-κB 
pathway. We found that Pellino3 deficiency enhanced formation of the death-induced 
signalling complex in response to TNF. Pellino3 directly interacts with DISC 
components, RIP1 and caspase-8, but not FADD. Furthermore we show that Pellino3 
regulates the formation of DISC and apoptosis in a manner that is dependent on the 
FHA domain but independent of the RING-like domain of Pellino3. The physiological 
importance of Pellino3 as a regulator of TNF signalling is confirmed by Pellino3-
deficient mice showing increased sensitivity to TNF-induced apoptosis and greatly 
increased lethality in response to TNF administration. These findings define Pellino3 as 
a novel regulator of TNF signalling and a critical determining factor in dictating 
whether TNF induces cell survival or death.   
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CHAPTER ONE: INTRODUCTION 
1.1 The immune system 
The immune system is an organism‟s defence system against disease and acts by 
identifying and killing invading pathogens. It protects the organism from bacterial, 
parasitic, fungal and viral infections and from the growth of tumor cells. The immune 
system is typically divided into two major branches: the innate immune system and the 
adaptive immune system. The latter is found only in vertebrates. 
1.1.1 The innate immune system 
The innate immune system reacts in a non-specific manner to the type of pathogenic 
threat. Its effects are immediate and initiated a very short time after exposure to an 
antigen. It has long been considered to be non-specific and that its main function is to 
contain infection until the adaptive immune response can be induced. However, in the 
last few years it has become clear that innate immunity shows some specificity and is 
able to discriminate molecular structures that are conserved among broad groups of 
microorganisms. For example, all gram-negative bacteria contain lipopolysaccharide 
(LPS) in the bacterial cell wall. A receptor that can recognize the conserved lipid A 
moiety of LPS has therefore the potential to detect the presence of virtually any gram-
negative bacteria infection. These molecular structures, like LPS, are known as 
pathogen-associated molecular patterns (PAMPs) and the receptors of the innate 
immune system that evolved to recognize them are called pattern-recognition receptors 
(PRRs). The innate immune defence is highly efficient at distinguishing self from non-
self, through the use of PRRs. 
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1.1.2 The adaptive immune system 
The adaptive immune system provides vertebrates with the ability to recognize and 
remember specific pathogens and react more quickly each time the pathogen is 
subsequently encountered. While all multicellullar organisms appear to have some form 
of host defence system, only vertebrates have developed the adaptive immune system 
(Thompson, 1995). There are two major branches of the adaptive immune responses: 
humoral immunity and cell-mediated immunity. Humoral immunity is mediated by B-
lymphocytes and involves the production of antibodies in specific response to an 
antigen. Cell-mediated immunity is mediated by T-lymphocytes and involves the 
activation of macrophages, natural killer (NK) cells, antigen-specific cytotoxic T-
lymphocytes, and the release of various cytokines in response to an antigen. The 
adaptive immune system, relying on clonally expressed receptors, has the advantage of 
flexibility and immunologic memory. However, the triggering of adaptive immunity is 
dependent on the innate immune system. The cooperation between the innate and 
adaptive immune systems leads to highly efficient recognition and elimination of 
pathogens (Clark and Kupper, 2005). 
1.1.3 The inflammatory response 
Inflammation, which is mainly due to cells of the innate immune system, is a complex 
biological response to harmful stress, such as pathogens, damaged cells or irritants. 
Inflammation is a protective attempt to prevent spreading of infection and to initiate the 
healing process. Inflammation is characterised by redness and swelling of tissue in the 
affected area and these symptoms are due to vasodilation of the blood vessels allowing 
cells of the immune system to congregate in the affected area. Inflammation is triggered 
by the recognition of danger-associated molecular patterns (DAMPs) or PAMPs and 
then facilitated by endogenous cytokines such as TNF and interleukin 1 (IL-1). 
Spontaneous secretion of TNF or IL-1β can also initiate inflammation. Once receptors 
such as Toll-like receptors (TLRs), TNF receptor (TNFR) and IL-1 receptor (IL-1R) are 
activated, various intracellular signal transduction pathways are initiated culminating in 
expression of inflammatory genes. 
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1.2 TLR signalling pathways 
1.2.1 TLRs 
The Toll protein was initially identified in Drosophia as a gene involved in dorsoventral 
polarity in the developing embryo. Subsequent studies have shown that the Toll protein 
plays an essential role in the defence against fungal infections (Lemaitre et al., 1996). 
Further studies led to the identification of a mammalian homolog of Toll, and this 
represented the characterisation of TLR4 as the first member of the TLR family 
(Medzhitov et al., 1997). To date, 13 mammalian TLRs (named TLR1 to TLR13) have 
been identified, 10 of which are found in humans. All TLRs are type I transmembrane 
proteins containing an extracellular leucine-rich repeat (LRR) domain, a transmembrane 
region, and a cytoplasmic Toll/IL-1 receptor (TIR) domain, which shares high sequence 
homology to the corresponding domain in the IL-1 receptor. The LRR domain has been 
inferred to be the ligand-sensing motif, responsible for molecular recognition (Kobe and 
Deisenhofer, 1995). All LRRs have a highly conserved segment. The repeat numbers 
and their distinct arrangement in TLRs differ with isoforms and species. The TIR 
domain of TLRs consists of approximately 150 amino acids and shows high similarity 
to that of the IL-1 receptor family. The TIR domain plays a central role in TLR 
signalling. It is present in both TLRs and adapter molecules and once the TLRs have 
bound their ligands, the TLR TIR domains act as a scaffold to recruit downstream TIR 
domain-containing adaptor proteins through TIR-TIR interactions (Dunne and O'Neill, 
2003). The structure of TLRs is presented in Figure 1-1. 
The TLR family members are expressed on the cells of the innate and adaptive immune 
systems. However, TLRs are differentially localized within the cell. TLR1, TLR2, 
TLR4, TLR5 TLR6 and TLR10 are all located on the cell surface, whereas TLR3, 
TLR7, TLR8 and TLR9 are located within the endosome and recognize intracellular 
pathogens. Each TLR recognizes distinct PAMPs  (Table 1-1) ( Roach et al., 2005).  
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Figure 1-1 TLR Structure. 
The mammalian TLR family are type I transmembrane proteins containing multiple leucine-rich repeats and one or 
two cysteine-rich regions in the large and divergent ligand-binding ectodomain; a short transmembrane region; and a 
conserved cytoplasmic domain TIR domain characterized by the presence of three highly homologous regions 
(known as boxes 1, 2 and 3). 
Adapted from (Akira and Takeda, 2004). 
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Receptor Ligands Origin of ligands 
TLR1 
 
Tri-acyl lipopeptides 
Soluble factors 
Bacteria, mycobacteria  
Neisseria meningitides  
TLR2 
 
 
 
 
 
 
 
 
 
 
 
Lipoprotein/lipopeptides 
Peptidoglycan 
Lipoteichoic acid 
Lipoarabinomannan 
A phenol-soluble modulin 
Glycoinositolphospholipids 
Glycolipids 
 Porins 
Zymosan 
Atypical LPS 
Atypical LPS 
LPS 
HSP70 
A variety of pathogens  
Gram-positive bacteria  
Gram-positive bacteria   
Mycobacteria   
Staphylococcus epidermidis   
Trypanosoma cruzi  
Treponema maltophilum  
Neisseria   
Fungi   
Leptospira interrogans  
Porphyromonas gingivalis 
Porphyromonas gingivalis  
Host  
TLR3 Double-stranded RNA Virus  
TLR4 LPS 
Taxol 
Fusion protein 
Envelope proteins 
HSP60 
HSP60 
HSP70 
Type III repeat extra domain A of fibronectin 
Oligosaccharides of hyaluronic acid 
Polysaccharide fragments of heparan sulfate 
Fibrinogen 
Gram-negative bacteria   
Plant   
RSV   
MMTV  
Chlamydia pneumoniae   
Host   
Host   
Host   
Host  
Host  
Host  
TLR5 Flagellin Bacteria  
TLR6 Di-acyl lipopeptides Mycoplasma  
TLR7 Imidazoquinoline 
Loxoribine 
Bropirimine 
Sigle-stranded RNA 
Synthetic compounds  
Synthetic compounds   
Synthetic compounds  
Virus 
TLR8 Imidazoquinoline 
Sigle-stranded RNA 
Synthetic compounds 
Virus 
TLR9 CpG DNA Bacteria  
TLR10 N.D. N.D. 
TLR11 Uropathogenic E.coli strains  
Profilin-like molecule 
Uropathogenic bacteria 
Table 1-1 Toll-like receptors and their ligands   
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N.D.: not determined        
Adapted from (Akira and Takeda, 2004)  
1.2.1.1 Extracellular TLRs 
TLR4 was the first TLR identified in mammals with the ability to recognize LPS, which, 
as mentioned, is a glycolipid component of the gram-negative bacterial cell wall 
(Poltorak et al., 1998). TLR4 requires some accessory proteins to recognize LPS, 
including CD14 (cluster of differentiation antigen 14), a glycosylphosphatidylinositol 
(GPI) -anchored membrane glycoprotein, and myeloid differentiation protein2 (MD2), a 
secretory protein. LPS is first transferred to soluble CD14 by a lipid transferase LPS-
binding protein (LBP) (Jiang et al., 2000). LPS is then delivered to the TLR4/MD2 
complex on the cell surface by CD14 (da Silva Correia et al., 2001). TLR4 can also 
recognize some other ligands including Taxol, an antitumor agent derived from a plant, 
fusion protein from respiratory syncytial virus (RSV), envelope proteins from moloney 
murine leukemia virus (MMLV), heat shock protein 60 (HSP60), HSP70, the extra 
domain A of fibronectin  oligosaccharides of hyaluronic acid, polysaccharide fragments 
of heparan sulfate and fibrinogen (Kawasaki et al., 2000; Kawasaki et al., 2000; Rassa 
et al., 2002; Bulut et al., 2002; Vabulas et al., 2002; Okamura et al., 2001;,  Termeer et 
al., 2002; Johnson et al., 2002; Smiley et al., 2001).  
The genes encoding TLR1, TLR2, TLR6 and TLR10 are closely related and show high 
sequence homology to each other. Overall, TLR1 shares 69.3% amino acid sequence 
identity with TLR6, but the TIR domains of both receptors exhibit over 90% identity. 
They have a similar genomic structure and locate in tandem on the same chromosome 
(Takeuchi et al., 1999; Takeda et al., 2003; Du et al., 2000). TLR2 has been reported to 
recognize a variety of different molecules from gram-positive and gram-negative 
bacteria, fungi, viruses and parasites (Miyake, 2007). This wide array of recognition is 
made possible by the collaboration of TLR2 either with TLR1 or TLR6, by virtue of the 
formation of heterodimers between TLR2 and TLR1or TLR6 (Ozinsky et al., 2000). 
From the sequence homology, TLR10 also belongs to the TLR1 gene family. It exists 
only in human as its expression has not been detected in mice. TLR10 can form 
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complexes as homodimers or heterodimers, in association with TLR1 or TLR2 (Hasan 
et al., 2005). 
TLR5 is expressed in monocytes, immature dendritic cells, endothelial cells, 
macrophages and epithelial cells (Vabulas et al., 2002). TLR5 can recognize flagellin, a 
protein that makes up the filament of bacterial flagella and plays important roles in 
bacterial chemotaxis, bacterial adherence and invasion of host tissues (Hayashi et al., 
2001). So far, flagellin is the only known ligand for TLR5. Although the focus of some 
research, the mechanism by which flagellin is recognized by TLR5 is still unknown 
(Jacchieri et al., 2003; Mizel et al., 2003).  
TLR11 is not expressed in human but has been detected in mouse bladder and kidney. It 
recognizes uropathogenic E.coli strains and a profilin-like molecule from intracellular 
protozoans such as Toxoplasma gondii (Yarovinsky et al., 2005). 
TLR12 and TLR13 have also been discovered in mouse, but remain to be characterised 
at the functional level. 
1.2.1.2 Intracellular TLRs 
TLR3, TLR7, TLR8 and TLR9 are all located in the intracellular endosome membrane, 
a prime location to recognize their PAMPs, viral and bacterial nucleic acids. 
Translocation of these TLRs from the endoplasmic reticulum (ER) to the endosome or 
endolysosome is dependent on the membrane protein UNC93B1 (Kim et al., 2008) and 
the ER-resident chaperone gp96 (Saitoh and Miyake, 2009). 
TLR3 recognizes double-stranded RNA (dsRNA), which is generated by many viruses 
during their replicative stages within host cells (Alexopoulou et al., 2001). TLR3 is 
unique amongst the other TLRs in that it lacks a critical proline residue that is highly 
conserved in the TIR domain of other TLRs. TLR3 protein is encoded by exons 2 
through 5, while other TLRs are encoded by only 1 or 2 exons (Hoshino et al., 1999). 
TLR3 is expressed in a variety cells such as T lymphocytes, NK cells, macrophages and 
mast cells. TLR3 is located in acidic endosomes where it binds dsRNA via its 
ectodomain (Gauzzi et al., 2010). Polyinosinic:polycytidylic acid (Poly (I:C)) is a stable 
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synthetic dsRNA analogue which is extensively used as a TLR3 ligand to 
mimic activation of TLR3 by viral infection (Field et al., 1967). 
TLR7 and TLR8 are similar in sequence and able to recognize single-stranded RNA 
(ssRNA), rich in guanosine or uridine, derived from viruses. TLR7 has also been 
reported to respond to synthetic antiviral imidazoquinoline compounds such as R848, 
loxoribine  and imiquimod (Hemmi et al., 2002;  Diebold et al., 2004; Heil et al., 2004). 
Furthermore TLR7 and TLR8 recognize synthetic oligoribonucleotides known as 
stabilized immune-modulatory RNA (SIMRA) compounds (Lan et al., 2007). Recently, 
a study on TLR8-deficient mice showed murine TLR8 had the ability to control TLR7 
expression, thereby regulating myeloid cells and preventing autoimmunity (Demaria et 
al., 2010). 
TLR9 recognizes unmethylated cytosine phosphate guanine (CpG) motifs of ssDNA, 
which is commonly present in bacteria and viruses. Activation of TLR9 induces 
secretion of cytokine and chemotactic factors and is involved in activation of 
proapoptotic signals (Theiner et al., 2008; Liang et al., 2010). 
1.2.2 TLR Signalling  
TLR-signal transduction can be broadly categorized into myeloid differentiation 
primary-response protein 88 (MyD88)-dependent and MyD88-independent pathways 
with the latter also termed the TIR-domain-containing adaptor protein inducing 
interferon β (TRIF)-dependent pathway. All TLRs, except TLR3, use the MyD88-
dependent pathway to activate NF-κB, p38 and c-Jun N-terminal kinse/stress-activated 
protein kinase (JNK/SAPK) mitogen-activated protein kinase (MAPK) pathways. TLR3 
and TLR4 are both capable of initiating the TRIF-dependent pathway, inducing 
inflammatory cytokines and type I interferons such as interferon-α and β (IFNα/β) 
(Bagchi et al., 2007). 
1.2.2.1 The MyD88-dependent pathway 
Upon stimulation by a cognate ligand, all TLRs, except TLR3, recruit MyD88, which 
has a TIR domain, an intermediary domain (ID) and a death domain (DD). In addition 
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to MyD88, TLR2 and TLR4 recruit MyD88-adaptor-like protein (MAL, also known as 
TIR-domain containing adapter protein, TIRAP), which serves as a bridge between the 
TIR domain of TLR2 and TLR4 and MyD88. MyD88 then recruits the members of the 
IL-1 receptor-associated kinase (IRAK) family with IRAK first being described as a 
protein kinase activity that co-precipitated with IL-1R1 (Martin et al., 1994). IRAK4 
binds to MyD88 by its DD, triggering hyperphosphorylation of IRAK1 and IRAK2 
(Kawagoe, et al. 2008). Activated IRAKs subsequently dissociate from MyD88 and 
interact with downstream adaptor TNFR-associated factor 6 (TRAF6), which acts as an 
E3 ubiquitin ligase. The complex associates with the pre-formed TGF-β-activated 
protein kinase 1 (TAK1) – TAK1 binding protein1 (TAB1)-TAB2-TAB3 complex. 
TAK1 then phosphorylates IKKβ in a complex with its related IKK kinase and the 
scaffolding protein IKKγ. The activated IKKβ can directly phosphorylate inhibitor of 
NF-κB (IκB) leading to its degradation allowing for NF-κB translocation into nucleus, 
where it initiates transcription of NF-κB responsive genes (Ninomiya-Tsuji, et al. 1999; 
O'Neill 2002).  
TAK1 also phosphorylates and activates MAPK kinase kinase (MKK) 3/6 and MKK7, 
resulting in downstream phosphorylation of both p38 and JNK MAPKs, respectively. 
P38 MAPK and JNKs can then translocate to the nucleus and regulate expression of 
their target genes (Wang, et al. 2001). 
Signalling molecules in the above pathway are subject to tight control and this is 
facilitated in many cases by their posttranslational modification. Phosphorylation and 
ubiquitination are especially important modifications that regulate these pathways. 
Reversible protein phosphorylation, principally on serine, threonine or tyrosine residues, 
is one of the most important posttranslational modifications that regulate the function, 
localization, and binding specificity of target proteins (Stock et al., 1989). Protein 
kinases and phosphatases are the enzymes responsible for determining the 
phosphorylation state of particular proteins. Protein kinases modify proteins by 
chemically adding phosphate groups to them, while protein phosphatases remove the 
phosphate group from its substrate by hydrolysing phosphoric acid monoesters into a 
phosphate ion and a molecule with a free hydroxyl group (Cohen, 1992). 
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Ubiquitination is another important reversible posttranslational modification, which 
regulates many biological processes including cell cycle progression, apoptosis, cell 
proliferation and DNA repair. Ubiquitin is a highly evolutionarily conserved 8-kDa 
polypeptide consisting of 76 amino acids, containing seven lysine (K) residues (K6, 
K11, K27, K29, K33, K48 and K63) that can participate in chain linkage formation 
(Baboshina and Haas, 1996). Ubiquitination occurs by the coordinated action of three 
distinct classes of enzymes named E1 (ubiquitin-activating enzyme), E2 (ubiquitin-
conjugating enzyme) and E3 (ubiquitin ligase). Ubiquitin is first activated by an E1, in 
an ATP-dependent reaction. The activated ubiquitin is then transferred to an E2, 
forming an E2-Ub thioester. The E2 enzyme-ubiquitin complex, in the presence of an 
E3 protein, is attached to a target protein via the C terminal glycine residue of ubiquitin 
and a lysine residue in the target protein (Alkalay et al., 1995). Following an initial 
monoubiquitination event, the covalently attached ubiquitin itself can be subjected to 
ubiquitination at one of its 7 lysine residues and this process can be repeated leading to 
the formation of an ubiquitin polymer and thus polyubiquitination of the target protein. 
Polyubiquitin chains, which are linked via linkages at their K48 residues, are 
recognized by the 26S proteasome leading to degradation of the ubiquitinated protein 
and the recycling of ubiquitin. The formation of K63-linked chains is not a signal for 
degradation but instead such chains act as docking site for the recruitment of various 
proteins. It is interesting to note that E3 ubiquitin ligases that catalyze K63-linked 
polyubiquitination also have a tendency to promote autoubiquitination (Deng et al., 
2000). TRAF-6 is one such E3 ligase that catalyzes the formation of K63-linked 
polyubiquitin chain on itself and this allows for its recruitment of the TAK-1/TAB and 
IKK complexes by virtue of the ubiquitin-binding domains of TAB proteins and IKKγ 
respectively (Xia, et al. 2009). This brings TAK1 into close proximity with the IKKs 
allowing for phosphorylation and activation of the latter by TAK1.  
Whilst most attention has focused on NF-κB as the major transcription factor that is 
activated by the Myd88 pathway, TLR7 and TLR9 can also employ MyD88 in 
plasmacytoid dendritic cells (pDCs) to activate IRF7 that induces type I interferon  
expression. In this pathway MyD88 recruits IRAK4, TRAF6, TRAF3 and IRAK1. IRF7 
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becomes phosphorylated in this complex allowing for its translocation into the nucleus 
where it can regulate IFN transcription (Kawai and Akira, 2008). 
1.2.2.2 The TRIF-dependent pathway 
The TRIF-dependent pathway or MyD88-independent signalling pathway is only 
initiated by TLR3 and TLR4. TLR4 is the only TLR that utilizes both the MyD88-
dependent pathway and the TRIF-dependent pathway (Amati et al., 2006; Foster et al., 
2007; O'Neill, 2006; Pandey and Agrawal, 2006). Unlike TLR3, TLR4 needs a bridging 
adaptor TRIF-related adaptor molecule (TRAM) for activating TRIF (Fitzgerald et al., 
2003). TRIF interacts with TRAF3 and TRAF6 through TRAF-binding motifs, which 
exist in its N-terminal portion to initiate downstream signalling. 
In response to TLR3, TRAF3 plays a critical pole in activating two IKK-related kinases; 
TRAF-family-member associated NF-κB activator (TANK)-binding kinase 1 (TBK1) 
and IKKε (also call inducible IKK or IKKi). Activation of TBK1 and IKKε leads to the 
phosphorylation of interferon regulatory factors 3 (IRF3) and IRF7. IRF3 and IRF7 
dimerise and in turn translocate to the nucleus, resulting in induction of type I IFNs and 
expression of IFN-inducible genes (Hacker et al., 2006).   
Although TRAF6 has been showed to interact with TRIF, its role in TRIF signalling is 
still controversial. In contrast to TRAF6-deficient mouse embryonic fibroblasts (MEFs), 
TRIF signalling was not affected in TRAF6-deficient macrophage (Gohda et al., 2004; 
Hacker et al., 2006). 
TRIF also recruits receptor interacting protein1 (RIP1) and RIP3 by its C-terminal RIP 
homotypic interaction motif (RHIM) (Meylan et al., 2004). RIP1 is then 
polyubiquitinated and  activates TAK1 resulting in the activation of the NF-κB pathway 
(Cusson-Hermance et al., 2005). RIP3 plays an inhibitory role in the TRIF-RIP1-NF-κB 
pathway.. 
The schematic representation of TLR pathway is presented in Figure 1-2. 
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Figure 1-2 Overview of TLR signalling pathways.    
Upon stimulation by a cognate ligand, all TLRs, except TLR3, recruit MyD88. In addition to MyD88, TLR2 and 
TLR4 recruit TIRAP, which serves as a bridge between the TIR domain of TLR2 and TLR4 and MyD88. MyD88 
then recruits the members of IRAK family. IRAK4 binds to MyD88 by its DD, triggering hyperphosphorylation of 
IRAK1 and IRAK2. Activated IRAKs subsequently dissociate from MyD88 and interact with downstream adaptor 
TRAF6. The complex associates with the pre-formed TAK1-TAB2-TAB3 complex. TAK1 then phosphorylates IKKβ 
in a complex with its related IKK kinase and the scaffolding protein IKKγ. The activated IKKβ can directly 
phosphorylate IκB leading to its degradation allowing for NF-κB translocation into nucleus, where it initiates 
transcription of NF-κB responsive genes. TAK1 also trigers phosphorylation of both p38 and JNK MAPKs. TLR7 
and TLR9 can also employ MyD88 in plasmacytoid dendritic cells to activate IRF7 that induces type I interferon  
expression. TLR3 and TLR4 both signal through the adaptor TRIF, which interacts with TRAF3 to activate the 
noncanonical IKKs, TBK1, and IKK  resulting in the dimerization and activation of IRF3, which then translocates 
into the nucleus activating the transcription of IFN and IFN-inducible genes. 
Adapted from (Loiarro, 2010)  
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1.3 IL-1R signaling pathway 
Whilst TLRs are primary triggers of the inflammatory response, inflammation can be 
triggered by TLR-induced expression of endogenous pro-inflammatory cytokines. IL-
1 is a key proinflammatory cytokine that plays a determining role in the regulation of 
a broad spectrum of immune and inflammatory responses. IL-1 can regulate a number 
of genes, including genes for other cytokines, cytokine receptors, acute-phase 
reactants, growth factors, tissue remodeling enzymes, extracellular matrix 
components and adhesion molecules (Dinarello, 1996; O'Neill, 1995). Furthermore, 
IL-1 can also induce expression of its own genes in a positive-feedback loop (Gaestel 
et al., 2009). Although the original IL-1 family comprised only IL-1α and IL-1β, more 
members of the IL-1 family have been identified, including IL-1R antagonist (IL-1Ra), 
IL-18, IL-36Ra, IL-36α, IL-37, IL-36β, IL-36γ, IL-38 and IL-33, which are encoded 
by 11 distinct genes (Dinarello, 2011). IL-1α and IL-1β are mainly produced by 
activated macrophages, monocytes and dendritic cells, but other cell types, such as 
epithelial cells (Hoffmann et al., 2005), endothelial cells (Bandman et al., 2002) and 
fibroblasts (Holzberg et al., 2003) can also make these cytokines.  
IL-1 signals through two distinct subunits of its receptor: IL-1R1 and IL-1R  
accessory protein (IL-1RacP). Once bound with IL-1, IL-1R and IL-1RacP form a 
complex, which recruits MyD88 and Toll-interacting protein (Tollip) to the receptor 
to facilitate downstream signal propagation. Competitive binding by IL-1Ra to IL-
1R1 can block such IL-1 mediated signalling (Aksentijevich et al., 2009).  Like TLRs, 
IL-1R1 utilises the MyD88-dependent pathway to activate NF-κB and this is due to 
IL-1R1 and TLRs sharing the TIR homology domain in their intracellular regions. 
MyD88 and Tollip serve as adaptors to recruit IRAK4 to the receptor allowing 
subsequent phosphorylation of IRAK1 and IRAK2. Tollip and IRAK1 exist as a 
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complex in resting cell, where Tollip blocks phosphorylation and the kinase activity 
of IRAK1 (Brissoni et al., 2006). After receptor activation, the complex is recruited to 
the receptor, resulting in the rapid autophosphorylation of IRAK1 and its dissociation 
from the receptor. In parallel, IRAK1 phosphorylates Tollip, leading to the 
dissociation of Tollip from IRAK1 and its rapid ubiquitylation and degradation. 
TRAF6 is subsequently recruited and activated as described previously for the 
MyD88-dependent pathway.  
The schematic representation of IL-R1 pathway is presented in Figure 1-3. 
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Figure 1-3 Signal transduction through IL-1R.   
After IL-1 is bound, a complex is formed between the IL-1R and IL-1RacP. The cytosolic proteins MyD88 and 
TolliP are recruited to this complex, where they function as adaptors, recruiting IRAK in turn. IRAK1 activates 
and recruits TRAF6 to the IL-1 receptor complex. Eventually, phosphorylated IRAK is ubiquitinated and degraded. 
TRAF6 activates two pathways, one leading to NF-κB activation and another leading to c-Jun activation. The 
TRAF associated protein ECSIT leads to c-Jun activation through the MAPK/JNK signaling system. TRAF6 also 
signals through the TAB1/TAK1  kinases to trigger the degradation of IκB, and activation of NF-κB.  
Adapted from  (https://www.qiagen.com/geneglobe/pathwayview.aspx?pathwayID=237 ) 
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1.4 TNFR signalling pathway  
1.4.1 TNF  
Like IL-1, TNF is a critical TLR-induced cytokine that orchestrates the inflammatory 
response. TNF was first discovered more than one hundred years ago. In 1984, TNF 
was isolated and its encoding cDNA was cloned and expressed (Haranaka et al., 
1984). Human TNF is synthesized as a 233 amino acid protein that is then cleaved to 
a 157 amino acid protein by TNF-converting enzyme (TACE) (Kriegler et al., 1988). 
A wide range of cells produce TNF. The primary sources in vivo are cells of 
monocytic lineage, such as macrophages, astroglia, microglia, langerhans cells, 
Kupffer cells and alveolar macrophages (Pfeffer et al., 1993). Although it was initially 
characterised as a cytokine that could kill tumor cells, TNF has been subsequently 
implicated in a wide arrange of biological processes such as cell proliferation, 
differentiation, apoptosis, lipid metabolism, insulin resistance, endothelial function 
and coagulation (Gaur and Aggarwal, 2003; Locksley et al., 2001). TNF is not 
detectable in the serum from a healthy individual. However, TNF is a critical 
component of effective immune surveillance and is required for proper proliferation 
and function of immune cells. TNF has been shown to play roles in a wide spectrum 
of human diseases, such as cancer, Alzheimer disease, heart failure, allograft rejection, 
diabetes (type II), cerebral malaria, acquired immunodeficiency syndrome, 
rheumatoid arthritis and Crohn's disease (Aggarwal, 2003). 
1.4.2 TNFR 
TNF signals through two receptors, TNFR1 (CD120a; p55/60) and TNFR2 (CD120b; 
p75/80) (Wallach et al., 1999). TNFR1 is expressed in most mammalian tissues 
whereas TNFR2 is mostly confined to immune cells. Containing four cysteine-rich 
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domains, the extracellular domains of TNFR1 and TNFR2 are highly conserved 
(Banner et al., 1993). TNFR1 has a special intracellular death domain containing 80 
amino acids, which is required for death signalling (Chen and Goeddel, 2002). 
However, TNFR2 does not contain a death domain (Grell et al., 1995). TNFR1 is the 
main signalling receptor for TNF in most cell types. TNF signalling can be regulated 
by controlling the processing and release of its receptor. Thus, in response to TNF 
stimulation, TNFR1 can be cleaved by a sheddase enzyme and shed from cells as  a 
34-kDa soluble TNFR1 (Reddy et al., 2000).  In the second pathway the full-length 
55-kDa TNFR1 can be released to the extracellular compartment within exosome-like 
vesicles (Hawari et al., 2004). 
1.4.3 TNFR downstream signaling 
TNF binding to TNFR1 triggers the activation of NF-κB leading to pro-inflammatory 
gene expression or activation of the caspase cascade, apoptosis / necroptosis leading 
to death (Chen and Goeddel, 2002; Galluzzi and Kroemer, 2008). These pathways are 
subject to counter-regulation and this is best appreciated by discussion of the 
signalling components of these pathways.  
1.4.3.1 Activation of NF-κB  
Upon binding of TNF, the trimerisation of TNFR1 will release silencer of death 
domain (SODD) (Jiang et al., 1999). This will result in the binding of TNF receptor –
associated death domain (TRADD) via its death domain (Jiang et al., 1999). TRADD 
then can recruit a number of additional proteins including TRAF2, TRAF5 and RIP1 
to form a new complex termed complex I (Chen and Goeddel, 2002). TRAF2 then 
recruits the E3 ubiquitin ligase cellular inhibitor of apoptosis protein1 (cIAP1) and 
cIAP2. The recruitment of cIAP1/cIAP2 causes the K63-linked ubiquitination of RIP1 
and TRAF2 (Ea et al., 2006). The K63-linked polyubiquitin chain on K377 in RIP1 
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serves as a scaffold to recruit the complex of TAK1 and TAB2/3. The newly formed 
complex subsequently activates the IKKα/β/γ heterocomplex. Activated IKK 
phosphorylates the NF-κB inhibitor IκBα resulting in its K48-linked ubiquitination 
and degradation of  IκBα allowing NF-κB dimers to translocate to the nucleus (Wu et 
al., 2006).  
Whilst NF-κB is a key driver of pro-inflammatory gene expression it can also 
promote the transcription of a series of prosurvival genes, such as cellular Fas-
associated death domain-like IL-1-β converting enzyme inhibitor protein 1 (cFLIP1), 
cIAP1, cIAP2, B cell lymphoma x (Bcl-x), X chromosome-linked IAP (XIAP) 
(Micheau et al., 2001; Mahoney et al., 2008; Tao et al., 2006; Dutta et al., 2006). 
These genes can inhibit and counter-regulate the caspase and apoptotic cascade that 
can also be triggered by TNF. 
1.4.3.2 Induction of Apoptosis 
Apoptosis, an important cell clearance mechanism, plays an essential role in multiple 
biological processes, including embryonic development, selection in the immune 
system, immune tolerance and many human diseases (Lawen, 2003). Apoptotic cells 
are characterised by several morphological changes, including cell shrinkage, plasma 
membrane blebbing, nuclear fragmentation, chromatin condensation and 
chromosomal DNA fragmentation. In contrast to necrosis, apoptosis produces 
compact membrane-enclosed structures, called apoptotic bodies, which are engulfed 
by macrophages and quickly removed before the contents of the cell can spill out onto 
surrounding cells and cause an inflammatory response (Saraste and Pulkki, 2000). 
Caspases are cysteine proteases that are the integral players during apoptosis and  are 
named due to their specificity for aspartic acid residues that precede their cleavage 
sites (Thornberry, 1997). Caspases are synthesized as inactive zymogens, termed 
procaspases. Upon maturation, the procaspases become proteolytically processed to 
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generate a small and a large subunit that assemble into active enzymes consisting of 
two large and two small subunits. The proapoptotic caspases can be divided into the 
group of initiator caspases, including caspase-2, -8, -9, -10, and executioner caspases, 
caspase-3, -6, -7. Initiator caspases cleave inactive pro-forms of executioner caspases, 
thereby activating them. Effector caspases in turn cleave a number of different target 
proteins within the cell to trigger the apoptotic process (Salvesen and Dixit, 1997). 
RIP1 is a key signalling molecule that determines whether TNF induces activation of 
NF-κB and survival or triggers apoptosis/necroptsis. When ubiquitinated by cIAP1 
and cIAP2, RIP tends to bias the TNF pathway towards activation of NF-κB whereas 
in its unubiquitinated form it promotes apoptosis. Several proteins are known to 
induce deubiquitination of RIP1. They include cylindromatosis (CYLD), cezanne, 
ubiquitin specific peptidase 21 (USP21) and A20 (Hitomi et al., 2008; Enesa et al., 
2008; Xu et al. 2010; Shembade et al., 2010). Wang et al. reported that second 
mitochondria-derived activator of caspase (SMAC) mimetics, which are tetrapeptides 
based on the amino acid sequence from the SMAC protein that binds to IAP family 
members and were originally designed to repress IAP inhibition of the caspases, can 
also favour increased levels of unubiqutinated RIP1 by accelerating cIAP1/2 
degradation (Wang et al., 2008). In its unubiquitinated state RIP1 can interact with 
Fas-associated death domain (FADD) protein via the DD of the latter. FADD 
subsequently recruits procaspase-8 through its death effector domain (DED). This 
complex is named death inducing signalling complex (DISC), also known as Complex 
II (Scaffidi et al., 1999). Procaspase-8 is then cleaved into the active p18/p12 
fragments by autoproteolytic self-activation (Ashkenazi and Dixit, 1998). Activated 
caspase-8 can either directly activate caspase-3, or cleave BH3 interacting domain 
death agonist (BID), a proapoptotic Bcl-2 family member (Scaffidi et al., 1998; 
Stennicke et al., 1998; Li et al., 1998; Stennicke et al., 1998). Truncated form of Bid  
(tBID)is then translocated to the mitochondria, resulting in the release of cytochrome 
c, apoptosis-inducing factor1 (Apaf1), caspase-9 and ATP, which will further activate 
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caspase-3 and caspase-7. Activated caspases then cleave intracellular substrates, 
triggering apoptosis (Li et al., 1998). RIP1 can also be cleaved by caspase-8 during 
this period, abolishing its NF-κB inducing ability. In addition, cleaved RIP1 can 
promote TRADD and FADD interaction (Lin et al., 1999b).  
Both of the apoptotic pathways described are tightly controlled by regulators of 
caspase activation. DISC can be inhibited by cFLIP, which can prevent the interaction 
between procaspase-8 and FADD by competitive binding to the former (Irmler et al., 
1997; Wang et al., 2008). TBid–induced apoptosis can be inhibited by Bcl2 or Bclx, 
which block cytochrome c release or by XIAP, which blocks caspase-9 activation 
( (Yi et al., 2003; Tao et al., 2006; Datta et al., 2000). The ability of NF-κB to induce 
cFLIP and Bcl2 underlies the counter-regulatory effects of NF-κB on the apoptotic 
pathway.  
1.4.3.3 Induction of necroptosis 
Necrosis refers to a caspase-independent cell death mechanism biochemically 
characterized by mitochondria swelling, nuclear flocculation and uncontrolled cell 
lysis (Golstein and Kroemer, 2007). Necrosis has been considered for a long time as 
an accidental, uncontrolled form of cell death. However, accumulating evidences 
show that necrotic cell death is regulated by complex signal transduction pathway, 
which is termed necroptosis (Degterev et al., 2005). Studies showed that cell death 
induced by necroptosis contributed to embryonic development and adult tissue 
homeostasis and like apoptosis necroptosis could be induced by specific ligands and 
regulated by genetic, epigenetic, and pharmacological factors (Golstein and Kroemer, 
2007). Necroptosis depends on the kinase activities of RIP1 and RIP3 (Degterev et al., 
2008; He et al., 2009). Identification of the RIP1 inhibitor, necrostatin-1 (Nec-1) 
made it possible to study the functions of RIP1 in regulating the downstream pathway 
of NF-κB activation, apoptosis and necroptosis (Degterev et al., 2005). 
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RIP3 plays a switch-like role in TNF-induced apoptosis and necroptosis (He et al., 
2009). RIP3 binds to RIP1 through their RHIM domains (Sun et al., 2002).  Activated 
caspase-8 inactivates RIP1 and RIP3 by proteolytic cleavage. If a caspase-8 
dependent apoptosis pathway is inhibited, necroptosis will occur after death receptor 
activation. RIP3 regulates the phosphorylation of RIP1. The complex will be further 
stabilized by the phosophorylation of RIP1 and RIP3 (Cho et al., 2009). RIP1 kinase 
inhibitor Nec-1 has also been reported to have the ability to prevent the recruitment of 
both RIP1 and RIP3 to complex I (He et al., 2009). RIP3 will interact with several 
bioenergetic enzymes such as glycogen phosphorylase (PYGL), glutamate-ammonia 
ligase (GLUL) and glutamate dehydrogenase (GLUD), further enhancing their kinase 
activity and triggering downstream reactive oxygen species (ROS) overproduction. 
Extra ROS, thereby can result in malfunction of mitochondria, leading to TNF-
induced necroptosis (Galluzzi and Kroemer, 2008). 
In addition, the complex containing TNFR1, TRADD, RIP1 recruits NADPH 
oxidase1 (NOX1) and the other signalling components NOX organizer 1 (NOXO1), 
NOX activator 1 (NOXA1) and Rac1. Upon activation of Nox1, NOXO1-TRADD 
interaction promotes oxidase activation, resulting in the generation of superoxide 
anions and hydrogen peroxide eventually contributing to necroptosis (Kim et al., 
2007). 
The schematic representation of TNFR1 pathway is presented in Figure 1-4. 
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Figure 1-4 TNFR1-elicited signalling pathways.  
A. In response to TNF-α stimulation, RIP1 is recruited to TNFR and forms a membrane associated complex I with 
TRADD, TRAF2/5 and cIAP1/2, which in turn leads to polyubiquitination of RIP1 and pro-survival NF-κB 
activation. B. when RIP1 is unubiquitinated by A20 or CYLD, deubiquitination of RIP1 leads to the formation of 
cytosolic DISC with FADD and caspase-8. Activation of caspase-8 in DISC leads to apoptosis induction. During 
apoptosis, RIP1 is cleaved and inactivated by caspase-8. C. In conditions where caspases are blocked or cannot be 
activated efficiently, RIP1 binds to RIP3 leading to necrosis. 
Adapted from (Murakami, 2011). 
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1.5 Downstream signalling in inflammatory pathways 
It is clear from above that the primary objectives of pro-inflammatory signalling 
pathways are to activate transcription factors like NF-κB and IRFs and to induce the 
expression of a range of pro-inflammatory genes.  
1.5.1 NF-κB  
NF-κB was discovered as a basally active nuclear factor necessary for transcription of 
the kappa light chain gene of activated B cells (Sen and Baltimore, 1986). However in 
many other cell types, NF-κB can serve as a first responder to harmful stimuli as the 
transcription factor is present in an inactive state in the cytosol forgoing the need for 
new protein synthesis to react to pathogenic threat. NF-κB inducing agents include 
ROS, TNF, IL-1β, TLR ligands, isoproterenol, cocaine and ionizing radiation. 
The NF-κB family has five conserved members in mammals: p50 (also known as NF-
κB1, precursor p100), p52 (also known as NF-κB2, precursor p100), p65 (RelA), 
RelB and cRel (Ghosh et al., 1998). All of the proteins have an N-terminal Rel 
homology domain, which is responsible for DNA binding, dimerization to other 
family members and binding to IκBs. P65, RelB and c-Rel have a C-terminal 
transactivation domain (TD), which is essential for transaction activity. In contrast 
p50 and p52 lack a TD (Wei, 2008 #324). NF-κB proteins can exist as either homo- or 
heterodimers. In the cytoplasm of unstimulated cells, the dimers are inactive due to 
their association with IκB proteins, IκBα, IκBβ, IκBγ and IκBε, which mask the 
nuclear localization sequences of NF-κB proteins (Karin and Ben-Neriah, 2000). NF-
κB is further regulated in the nucleus by the nuclear IκB family members IκBδ, 
IκBNS and Bcl-3 (Yamamoto and Takeda, 2008). 
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There are two signalling pathways leading to the activation of NF-κB, known as 
classical and the alternative pathways. Signalling through TNFR, IL-1R or TLRs, as 
described above, leads to activation of the classical NF-κB pathway. In response to 
stimulation, the IKK complex comprising IKKα, IKKβ and IKKγ is activated and 
phosphorylates IκB, leading to IκB polyubiquitylation and degradation. Liberated 
from IκB, p50-RelA heterodimers can then translocate from the cytoplasm into the 
nucleus, triggering the transcription of a plethora of genes (Zandi et al., 1997). The 
non-canonical pathway is responsible for the activation of p52/RelB complexes and 
regulates the generation of B and T lymphocytes. In this pathway, NF-κB inducing 
kinase (NIK) is activated upon ligand-receptor association, resulting in 
phosphorylation and activation of IKKα-IKKα complex. The activated IKKα complex 
in turn phosphorylates and subsequently induces proteasomal processing of the 
precursor protein p100 into a mature p52 subunit. P52-RelB heterodimers then 
translocate to nucleus and regulate a distinct class of genes (Dejardin, 2006). 
The extensive list of NF-κB inducible genes includes genes for proinflammatory 
cytokines such as IL-1, IL-6 and TNF, as well as genes for chemokines such as IL-8 
and RANTES (regulated upon activation normal T cell expressed and secreted) 
(Ghosh et al., 1998). NF-κB also upregulates the expression of cell adhesion 
molecules and induces a number of growth factors and antiapoptotic proteins. These 
proteins take part in many aspects of inflammatory response and NF-κB enhances the 
host cell division and inhibits apoptosis in response to harmful stimuli. 
The schematic representation of NF-κB pathway is presented in Figure 1-5.  
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Figure 1-5 Activation of NF-κB by the alternative and the classical pathways.  
Left: classical NF-κB pathway. In response to stimulation, the IKK complex comprising IKKα, IKKβ and IKKγ is 
activated and phosphorylates IκB, leading to IκB polyubiquitylation and degradation. Liberated from IκB, p50-
RelA heterodimers can then translocate from the cytoplasm into the nucleus, triggering the transcription of a 
plethora of genes. Right: non-canonical pathway. In this pathway, NIK is activated upon ligand-receptor 
association, resulting in phosphorylation and activation of IKKα-IKKα complex. The activated IKKα complex in 
turn phosphorylates and subsequently induces proteasomal processing of the precursor protein p100 into a mature 
p52 subunit. P52-RelB heterodimers then translocate to nucleus and regulate a distinct class of genes. 
Adapted from (Weih and Caamano, 2003) 
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1.5.2 MAPK 
MAPK pathways exist in all eukaryotic cells, regulating cellular activities from 
proliferation, differentiation, development and transformation to apoptosis. There are 
3 extensively studied groups of mammalian MAPKs including the extracellular 
signal-regulated kinase (ERK), JNK/SAPK and p38 MAPK. In general, ERK1 and 
ERK2 are activated in response to growth factors and phorbol esters and function in 
regulating meiosis, mitosis, and postmitotic processes in differentiated cells (Johnson 
and Lapadat, 2002). The JNK and p38 kinases are more responsive to stress stimuli 
such as cytokines, ultraviolet irradiation, heat shock, and osmotic shock and are 
involved in cell differentiation and apoptosis (Chen et al., 2001). 
Each family of MAPKs is composed of a set of three evolutionarily conserved kinases, 
which are activated in series: a MAPK, a MAPKK (MAPK kinase) and a MAPKKK 
(MAPKK kinase). To date, at least 14 MAPKKKs, 7 MAPKKs, and 12 MAPKs have 
been identified in mammalian cells (Widmann et al., 1999). Stimuli from outside the 
cell initiate the cascade in which MAPKKK phosphorylates and activates a dual-
specificity protein kinase (MAPKK) that, in turn, phosphorylates and activates a MAP 
kinase. MAPK cascade specificity is decided by the substrate selection. Through this 
way information is sent to the nucleus. 
The schematic representation of MAPK pathway is presented in Figure 1-6. 
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Figure 1-6 MAP kinase activation by innate immunoreceptors. 
Stimuli from outside the cell initiate the cascade in which MAPKKK phosphorylates and activates a dual-
specificity protein kinase (MAPKK) that, in turn, phosphorylates and activates a MAPK. MAPK cascade 
specificity is decided by the substrate selection. Through this way information is sent to the nucleus.  
Adapted from (Symons et al., 2006) 
1.5.3 IRFs 
IRFs were originally characterised as transcriptional regulators of IFN, which are 
responsible for inducing transcription of antiviral genes and inhibiting viral 
replication (Mamane et al., 1999). There are nine members of the IRF family 
identified so far. All IRFs have a N-terminal DNA-binding domain, characterized by 
five tryptophan repeat elements located within the first 150aa of the protein, which 
mediates binding to specific promoter sequences in IFN-stimulated genes. IRF 
proteins interact with other family members or other factors through their C-terminal 
IRF-association domain (Honda et al., 2006).  IRF3, IRF5 and IRF7 were reported to 
serve as direct transducers of virus-mediated signalling and play an essential role in 
the transcription of IFNα/β (Barnes et al., 2003). IRF3 and IRF-7 are involved in the 
TLR3/TLR4 pathways. TBK-1 and IKKε phosphorylate IRF3 and IRF7 on their c-
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terminal, resulting in IRF homo- and hetero-dimerization, nuclear localization, and 
association with the co-activator CBP/p300 (Lin et al., 1999a). 
1.6 The Pellino family 
Pellino was first identified as a protein that interacts with Pelle, the Drosophila 
homologue of IRAK, in a yeast two-hybrid screen (Grosshans et al., 1999). There are 
four closely related mammalian isoforms described to date, named Pellino1, Pellino2, 
Pellino3 short and long (Rich et al., 2000; Resch et al., 2001; Jensen and Whitehead, 
2003b). The protein sequences of the three mammalian Pellino proteins are highly 
conserved (Figure 1-). Pellino1 shares 82% amino acid sequence identity with 
Pellino2, whilst Pellino3 has 84-85% amino acid identity with Pellino1 and Pellino2, 
respectively (Jiang et al., 2003). The Pellino3 splice variants are 27aa and 25aa longer 
than Pellino1 and Pellino2 with an additional leader sequence respectively at their N 
terminus. Pellino3 long also has a 24aa insert at the N terminus compared with 
Pellino3 short (Jensen and Whitehead, 2003b). The Pellino proteins are also highly 
conserved among different species, hinting at an important function (Griffin et al., 
2011; Haghayeghi et al., 2010). 
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Sequence identity is represented by black shading and sequence similarity by grey shading. 
 
 
PRISM     1 ---------------------------MFSPDQE--NHPSKAPVKYGELIVLGYNGSLPN 
PRISM2    1 ---------------------------MFSPGQEEHCAPNKEPVKYGELVVLGYNGALPN 
PRISM3    1 MVLEGNPEVGSPRTSDLQHRGNKGSCVLSSPGED--AQPGEEPIKYGELIVLGYNGCLAS 
 
 
PRISM    32 GDRGRRKSRFALFKRPKANGVKPSTVHIACTPQAAKAISNKDQHSISYTLSRAQTVVVEY 
PRISM2   34 GDRGRRKSRFALYKRPKANGVKPSTVHVISTPQASKAISCKGQHSISYTLSRNQTVVVEY 
PRISM3   59 GDKGRRRSRLALSRRSHANGVKPDVMHHISTPLVSKALSNRGQHSISYTLSRSHSVIVEY 
 
 
PRISM    92 THDSNTDMFQIGRSTESPIDFVVTDTVPGSQSNSDTQSVQSTISRFACRIICERNPPFTA 
PRISM2   94 THDKDTDMFQVGRSTESPIDFVVTDTISGSQNTDEAQITQSTISRFACRIVCDRNEPYTA 
PRISM3  119 THDSDTDMFQIGRSTENMIDFVVTDTSPGG-GAAEGPSAQSTISRYACRILCDRRPPYTA 
 
 
PRISM   152 RIYAAGFDSSKNIFLGEKAAKWKTSDGQMDGLTTNGVLVMHPRNGFTEDSKPGIWREISV 
PRISM2  154 RIFAAGFDSSKNIFLGEKAAKWKNPDGHMDGLTTNGVLVMHPRGGFTEESQPGVWREISV 
PRISM3  178 RIYAAGFDASSNIFLGERAAKWRTPDGLMDGLTTNGVLVMHPAGGFSEDSAPGVWREISV 
 
 
PRISM   212 CGNVFSLRETRSAQQRGKMVEIETNQLQDGSLIDLCGATLLWRTAEGLSHTPTVKHLEAL 
PRISM2  214 CGDVYTLRETRSAQQRGKLVESETNVLQDGSLIDLCGATLLWRTADGLFHTPTQKHIEAL 
PRISM3  238 CGNVYTLRDSRSAQQRGKLVENESNVLQDGSLIDLCGATLLWRTPAGLLRAPTLKQLEAQ 
 
 
PRISM   272 RQEINAARPQCPVGFNTLAFPSMKR-KDVVDEKQPWVYLNCGHVHGYHNWGNKEERDGKD 
PRISM2  274 RQEINAARPQCPVGLNTLAFPSINR-KEVVEEKQPWAYLSCGHVHGYHNWGHRSDTEANE 
PRISM3  298 RQEANAARPQCPVGLSTLAFPSPARGRTAPDKQQPWVYVRCGHVHGYHGWGCRRERGPQE 
 
 
PRISM   331 RECPMCRSVGPYVPLWLGCEAGFYVDAGPPTHAFSPCGHVCSEKTTAYWSQIPLPHGTHT 
PRISM2  333 RECPMCRTVGPYVPLWLGCEAGFYVDAGPPTHAFTPCGHVCSEKSAKYWSQIPLPHGTHA 
PRISM3  358 RECPLCRLVGPYVPLWLGQEAGLCLDPGPPSHAFAPCGHVCSEKTARYWAQTPLPHGTHA 
 
 
PRISM   391 FHAACPFCAHQLAGEQGYIRLIFQGPLD 
PRISM2  393 FHAACPFCATQLVGEQNCIKLIFQGPID 
PRISM3  418 FHAACPFCGAWLTGEHGCVRLIFQGPLD 
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Figure 1-  
Figure 1-7 An alignment of the amino acid sequences of human Pellino1, 2 and 3 
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All Pellino proteins contain a C-terminal really interesting new gene (RING)-like 
domain. The classical RING domain contains a Cys3HisCys4 amino acid motif, 
which can bind two zinc atoms, whilst the RING-like domain of the Pellino proteins 
is CysHisCys2CysHisCys2 (Ardley and Robinson, 2005). Many proteins containing a 
RING domain have an E3 ubiquitin ligase activity. Both recombinant and endogenous 
forms of Pellinos have been shown in in vitro ubiquitination assays to possess E3 
ligase activity, which confers the ability of Pellinos to directly catalyse K63-linked 
polyubiquitination of IRAK (Ordureau et al., 2008). However, the RING domain of 
Pellino proteins is not required for IRAK1 binding (Lin et al., 2008). Intriguingly, 
IRAK-Pellino interactions also result in polyubiquitylation of the Pellino proteins, 
which subsequently trigger Pellinos degradation (Butler et al., 2007). Although 
Pellinos possess the ability to mediate K63-linked polyubiquitination, Pellino proteins, 
in an in vitro setting, can catalyse the formation of K48-linked polyubiquitin chains 
(Ordureau et al., 2008).  
Furthermore, Lin, et al. resolved an X-ray structure of the N-terminal fragment of 
Pellino2, which lacks the RING-like domain (Lin et al., 2008). They found that the 
Pellino proteins contain a cryptic phospho-threonine-binding forkhead-associated 
(FHA) domain at their N-terminal region (Figure 1-8). The FHA domain is known as 
a modular phospho-serine/threonine recognition motif, through which Pellino proteins 
interact with phosphorylated IRAK1 (Lin et al., 2008). The FHA domain in Pellino 
proteins contains an appendage or wing composed of two inserts, which is different to 
the classical FHA domain (Figure 1-9) (Lin et al., 2008). Pellino proteins are 
phosphorylated when co-expressed with IRAK1 and this has also been confirmed in 
in vitro kinase assays (Schauvliege et al., 2006; Ordureau et al., 2008).  However, a 
viral form of Pellino, which contains a FHA domain but lacks a complete and 
functional RING-like domain fails to post-translational modify IRAK1 (Griffin et al., 
2011). 
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Thus, it seems that there is a bi-directional communication between IRAK and 
Pellinos. Phosphorylation of Pellino by IRAK1 leads to the activation of E3 ligase and 
the polyubiquitination of both IRAK1 and Pellino. Whilst the polyubiquitylation of 
Pellino proteins leads to their degradation, this is independent of the proteins RING 
domain (Butler et al., 2007; Smith et al., 2009). The K63-linked polyubiquitylation of 
IRAK is proposed to regulate several downstream pathways, such as NF-κB and 
MAPK cascades (Conze et al., 2008). 
 
 
Figure 1-8 Structure–function characteristics of mammalian Pellino proteins. 
Each Pellino protein has a C-terminal RING-like domain that confers E3 ubiquitin ligase activity and a 
phosphothreonine-binding FHA domain in its N terminus that might facilitate interaction with phosphorylated 
IRAK1. The C-terminal regions of Pellino proteins can also interact with TRAF6 and TAK1 and the formation of 
these complexes, together with Pellino-induced polyubiquitylation of IRAK1.  
Adapted from  (Moynagh, 2009). 
FHA domain RING-like domainPellinoNH2 COOH
IRAK1 TRAF6 TAK1
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Figure 1-9 The IRAK1-binding region of Pellino2 is an FHA-like domain. 
(A) Cartoon views of the Pellino2 structure with the FHA core in green and the non-canonical wing in blue (amino 
acids 51-98 and 159-184 in dark and light blue, respectively). b strands of the FHA core are numbered 1-11, while 
those of the wing are 10-60. The N- and C-termini are labeled, as are the amino acids numbers at the beginning 
and end of each missing loop. (B) Topology diagram of Pellino with the strands colored as in A. Missing loops are 
shown with dashed lines. The position of b9 in canonical FHA domains is shown in gray. (C) The domain 
architecture of Pellino2.  
Adapted from (Lin et al., 2008) 
1.6.1 Pellino1 
On the basis of overexpression and RNAi studies, Pellino1 was shown to be involved 
in IL-1R and MyD88-dependent TLR signalling. Pellino1 was proposed to serve as a 
scaffolding protein, releasing IRAKs and TRAF6 from the IL-1R and subsequently 
allowing the protein to interact with TAK1/TAB1/TAB2 complex, and eventually 
resulting in the activation of NF-κB activation (Jiang et al., 2003). Pellino1 is also 
subject to regulation and has been shown to be modified by phosphorylation and 
Chapter one-Introduction 
 
33 
ubiquitination (Butler et al., 2007; Smith et al., 2009).  Recently studies have also 
showed that Pellino1 was subject to small-ubiquitin-related-modifier (SUMO) 
modification (Kim et al., 2011). Furthermore, the inhibitory proteins Smad6 that 
negatively regulate TGF- superfamily signalling, also targets Pellino1 and inhibits 
the formation of the Pellino1-IRAK4-IRAK1-TRAF6 complex. This mediates the 
inhibitory effects of TGF- on the proinflammatory IL-1R signalling pathway (Choi 
et al., 2006). Whilst cell lines studies indicated a role for Pellino1 in IL-1R signalling 
the generation of Pellino1 knockout mice showed Pellino1 was dispensable for IL-1R 
signaling (Chang et al., 2009). Studies in Pellino1-deficient mice found that Pellino1 
mediated IKK-NF-κB activation and regulated RIP1 ubiquitination in response to 
LPS and poly(I:C) stimulation. Also the serum concentration of proinflammatory 
cytokines such as TNF, IL-6, IL-12 was severely attenuated in Pellino1
-/- 
mice after an 
intraperitoneal injection of LPS or poly(I:C) (Chang et al., 2009). Both transcription 
of the gene encoding Pellino1 and Pellino1 protein expression increased in response 
to the stimulation of LPS or poly(I:C) via a TRIF-dependent pathway. Such 
expression of Pellino1 was also subject to regulation by IKKε/TBK1 (Smith et al., 
2011). These studies demonstrated that Pellino1 plays a non-redundant role as an E3 
ubiquitin ligase in the TRIF-dependent TLR3 and TLR4 signalling pathway. 
1.6.2 Pellino2  
The functional role of Pellino2 in IL-1R or TLR signalling remains uncertain. 
Although overexpression of murine Pellino2 does not enhance the expression of NF-
κB-regulated promoters gene, the reduction of Pellino2 expression levels inhibited IL-
1 dependent activation of NF-κB-regulated promoters in a MEF cell line (Yu et al., 
2002). However, human Pellino2 appears to have no effect on IL-1 or LPS induced 
NF-κB activation (Liu et al., 2004). Human Pellino2 has been identified as a substrate 
for IRAK1 and IRAK4. Pellino2 serves a similar function as Pellino1, in that it can 
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trigger and regulate the translocation of IRAKs from IRAK-TRAF6 complex to the 
TAK1/TAB1/TAB2 complex. Pellino2 has also been suggested to play a generic role 
in the transcription machinery (Strelow et al., 2003). Studies have also shown that 
Pellino2 can drive the activation of ERK1/2 and JNK pathway (Jensen and Whitehead, 
2003a). Another study demonstrated that Pellino2 can interact with Bcl10, an 
intracellular activator (Liu et al., 2004). Bcl10, as a binding partner of Pellino2, is 
recruited to TLR4 and activates NF-κB in response to LPS. Suppressor of cytokine 
signalling 3 (SOCS3) blocks the interaction between Bcl10 and Pellino2 and inhibits 
the downstream activation of NF-κB (Liu et al., 2004). Pellino2 was also identified as 
one of three genes, Pellino2, IL-8 and ubiquitin-conjugating enzyme E2-UBE2V1, 
with significantly increased expression between chronic allograft nephropathy and 
vascular acute rejection using a microarray analysis of 128 genes involved in TLR 
signaling (Nogueira et al., 2009). 
1.6.3 Pellino3 
Pellino3 mRNA is expressed in most tissues, whilst the highest expression levels are 
observed in brain, heart and testis (Jensen and Whitehead, 2003b). Pellino3 proteins 
can directly interact with IRAK1, TRAF6, TAK1 and NIK (Jensen and Whitehead, 
2003b). Although Jensen et al. showed that the overexpression of Pellino3 promoted 
the activation of JNK and ERK MAPK pathways; Xiao et al. found that the 
knockdown of the endogenous expression of Pellino3, induced JNK activation in 
response to IL-1 stimulation (Xiao et al., 2008). In contrast to Pellino1 and Pellino2 
that are ineffective in promoting the activation of p38 MAPK, Pellino3 activates this 
pathway (Butler et al., 2005). Both TRAF6 and TAK1 are key downstream mediators 
of Pellino3, as p38 MAPK is not activated when co-expressed with their dominant 
negative counterparts. Also the binding sites for TRAF6 and TAK1 are located at the 
C-terminus of Pellino3. Pellino3 promotes the activation of MAPK-activated protein 
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kinase2, which is a p38 substrate, and activates the transcription factor cAMP 
response element-binding protein (CREB) in a p38 MAPK-dependent manner. 
Tyrosine residue 44 in Pellino3 is an important functional site for triggering the 
activation of the p38 MAPK pathway. Although this residue is conserved in all 
members, it is only required for the interaction between Pellino3 with IRAK1 (Butler 
et al., 2005). 
A recent report has proposed that in response to IL-1, Pellino3 promotes a K63-linked 
polyubiquitylation of IRAK1, which competes with K48-linked polyubiquitylation at 
the same Lys134 reside on IRAK1 (Lin et al., 2008). Therefore, it was proposed that 
Pellino3 inhibits IL-1-induced activation of NF-κB by blocking the degradation of 
IRAK. However, the role of K48-linked polyubiquitylation in IRAK degradation has 
been debated, since IL-1-induced degradation of IRAK1 was not blocked by 
inhibition of the proteolytic activity of the proteasome (Windheim et al., 2008).  
Although the exact mechanism underlying the inhibitory effects of Pellino3 on the 
NF-κB pathway is not completely understood, the proposed negative regulatory role 
for Pellino3 is still interesting and suggests it as an important regulator in TLR and 
IL-1R signalling pathways. 
To date studies on the role of the Pellino family in innate immunity have been mostly 
confined to IL1 and TLR pathways with relatively little information available on their 
role in the TNF pathway. This study addresses this deficit by investigating the role of 
Pellino3 as a regulator of the TNF signalling pathway.  
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1.7 Project aims 
The specific aims of this project were to: 
- probe the role of Pellino3 in TNF-induced cell death 
- determine the importance of Pellino3 in regulation of NF-κB and MAPK 
activation in response to TNF 
- define the influence of Pellino3 on TNF-induced formation of DISC 
- identify Pellino3-interacting proteins in the TNF pathway 
- define the physiological role of Pellino3 in the TNF pathway 
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CHAPTER TWO: MATERIALS AND METHODS 
2.1 MATERIALS 
2.1.1 Reagents 
Reagents Supplier 
Agar Sigma 
Agarose Promega 
Agarose, low melting point Sigma 
Ampicillin Sigma 
APS Sigma 
Bovine serum albumin (BSA) Sigma 
Bradford reagent dye Bio-Rad 
Bromophenol blue Sigma 
Chloroform Sigma 
Clonables™ 2X Ligation Premix Merck 
Coomassie Blue (G250) Sigma 
Cycloheximide (CHX) Sigma 
DAB (3,3'-Diaminobenzidine) Vector Labs 
DAPI (4',6-Diamidino-2-Phenylindole) Sigma 
DEPC (diethylpyrocarbonate)-treated water Ambion 
D-galactosamine (D-Gal) Sigma 
DMEM (Dulbecco's Modified Eagle's medium) Invitrogen 
DMSO (dimethyl  sulfoxid) Sigma 
DNA ladder & Loading dye Promega 
dNTPs (deoxyribonucleotide triphosphates) Promega 
DTT (dithiothreitol ) Sigma 
E.coli - TOP10 competent cells Invitrogen 
EDTA (ethylenedia~nine tetra-acetic acid) Sigma 
Ethanol Sigma 
Ethidium bromide Sigma 
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FBS (fetal bovine serum) Invitrogen 
Formalin solution Sigma 
Glacial acetic acid Merck 
Glycerol Sigma 
Glycine Sigma 
GoTaq® Green Master Mix Promega 
HEPE (hydroxyeicosapentaenoic acid) Sigma 
Hoechst 33342 Sigma 
hydrochloric acid (HCl) Merck 
Hydrogen peroxide solution (H2O2) Sigma 
Igepal Sigma 
Imidazole Sigma 
Isopropanol Sigma 
IPTG (isopropyl β-D-1 thiogalactopyranoside) Sigma 
Kanamycin Sigma 
Lipofectamine 2000 Invitrogen 
Lysogeny broth (LB) Sigma 
Magnesium Chloride Sigma 
Methanol BDH 
Microlon 96-well plates Greiner 
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
Protech 
Ni-NTA (nickel-nitrilotriacetic acid) Resin Qiagen 
NF-κB IRDye Labelled Oligonucleotides Licor Biosciences  
OptiMEM Invitrogen 
PBS (Phosphate buffered saline) Oxoid 
Penicillin / Streptomycin / Glutamine Invitrogen 
PMSF (phenylmethylsulfonyl fluoride) Sigma 
Polybrene Sigma 
Prestained molecular weight marker  Invitrogen 
Protease inhibitor mixture Roche 
Protease inhibitor mixture (EDTA free) Roche 
Protein A/G-agarose Santa Cruz 
Protogel National Diagnostics 
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Puromycin Sigma 
Random primers Invitrogen 
Restriction enzymes NewEngland 
RNase Zap Ambion 
SDS (sodium dodecyl sulphate) Sigma 
siRNA Pellino3 specific Ambion 
siRNA Lamin a/c Ambion 
Skim milk powder Sigma 
Sodium chloride (NaCl) Sigma 
Sodium hydroxide (NaOH) Sigma 
Sodium orthovanadate (Na3VO4) Sigma 
Sodium Phosphate (Na3PO4) Sigma 
Sulphuric acid (H2SO4) Sigma 
Synthetic oligonucleotides MWG Biotech 
Taq polymerase Invitrogen 
TEMED (N, N, N′, N′-tetramethylethylenediamine) Sigma 
TMB (3, 3‟, 5, 5‟-Tetramethylbenzidine liquid substrate ) Sigma 
TNFα R&D Systems 
Tris-base Sigma 
Tris-HCl Sigma 
Trypsin/EDTA Invitrogen 
Tween-20 Sigma 
Z-VAD-FMK (benzyloxycarbonyl-valine-alanine-aspartate-fluoromethyl ketone) 
Promega. 
2.1.2 Kits 
Kits Supplier 
EMSA (Electophoretic Mobility Shift Assay) Buffer Kit Licor Biosciences 
DeadEnd
TM
 Fluorometric TUNEL System  Promega 
GC-RICH PCR system Roche 
M-MLV RT (Reverse Transcriptase) 1st-Strand cDNA Synthesis Kit  
 Promega 
Mouse IL-10 ELISA (Enzyme-Linked Immunosorbent Assay) kit           
 R&D Systems 
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Mouse Rantes ELISA kit R&D Systems 
Mouse TNFα ELISA kit Protech 
Plasmid Plus Midi Kit Qiagen 
Plasmid Mini Kit Qiagen   
Qiaquick PCR Purification Kit Qiagen 
Vectastain ABC kit  Vector Laboratories 
2.1.3 Antibodies 
Antibodies Supplier 
β-actin Sigma 
Bcl-x Cell Signalling 
ERK Cell Signalling 
FLAG M2 Sigma 
His-HRP (horseradish peroxidase) Sigma 
HA-Tag (6E2) Cell Signalling  
IκB-α Santa Cruz 
JNK Cell Signalling 
Myc-Tag (9B11) Cell Signalling  
P38 Cell Signalling 
Pellino3 Santa Cruz 
Phosho-ERK Cell Signalling                               
Phosho-IκB-α Cell Signalling                               
Phosho-JNK Cell Signalling    
Phosho- p38 Cell Signalling    
RIP1 Transduction Labs 
cleaved caspase-8 Cell Signalling 
FADD ENZO 
PARP (Poly-ADP-ribose- polymerase) Cell Signalling 
IKK-β Cell Signalling 
caspase-8 Santa Cruz 
cleaved caspase-3 Cell Signalling 
Phospho-IKK-α/β Cell Signalling 
Secondary Antibodies： Supplier 
Anti-mouse / rabbit-HRP Cell Signalling 
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IRDye 800CW Goat Anti-Rabbit Licor Biosciences 
IRDye 680 Goat Anti-Mouse Licor Biosciences 
IRDye 800CW Donkey Anti-goat Rockland 
2.1.4 Buffers 
Buffer  Composition  
PBS 2.7mM KCl, 1.5mM KH2PO4, 137mM NaCl, 
 8mM Na2HPO4, pH 7.4  
TBS (Tris buffered saline) 25mM Tris, pH7.4, containing 0.14M NaCl. 
Blocking Buffer 1X TBS, 0.1% (v/v) Tween-20 with 
 5 % w/v nonfat dry milk or 5% w/v BSA 
Cell lysis Buffer 20 mM Tris-HCl, pH 7.4, 150 mM NaCl,  
 0.2% (v/v) Igepal, 10% (w/v) glycerol, 50 mM  
 NaF,1 mM Na3VO4, 1 mM DTT, 1 mM PMSF, 
 complete protease inhibitor cocktail (Roche, mini)  
EMSA Buffer-A  10 mM HEPES pH 7.9, 10 mM KCl,  
 1.5 mM MgCl2, shortly before use add: 0.5 mM DTT  
 and 0.5 mM PMSF 
EMSA Buffer-C  20 mM HEPES pH 7.9, 420 mM NaCl,  
 1.5 mM MgCl2, 0.2 mM EDTA, 25% (w/v) glycerol 
 shortly before use add: 0.5 mM PMSF 
EMSA Buffer-D 10 mM HEPES pH 7.9, 50 mM KCl, 0.2 mM  
 EDTA, 20% (w/v) glycerol, shortly before use add:  
 0.5 mM PMSF and 0.5 mM DTT 
In Vitro Binding Buffer 20 mM Tris-HCl, pH 7.4, 150 mM NaCl,  
 0.2% (v/v) Igepal, 10% (w/v) glycerol  
 and complete protease inhibitor cocktail 
Laemmli sample buffer  62.5 mM Tris-HCl, pH 6.8, 10% (w/v) glycerol, 
(1x Concentrations) 2% (w/v) SDS, 0.7 M β-mercaptoethanol , 
 0.001% (w/v) bromophenol blue 
Qiagen native lysis buffer 50 mM NaH2PO4.H2O, 300 mM NaCl 
 10 mM Imidazole, 10mM β-mercaptoethanol 
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Qiagen native wash Buffer 50 mM NaH2PO4.H2O, 300 mM NaCl, 
20 mM Imidazole 
Qiagen native elution Buffer 37.5 mM NaH2PO4, 225mM NaCl,  
250 mM Imidazole 
SDS running Buffer 25 mM Tris, 192 mM glycine, 0.1% SDS. 
SOC medium  2% peptone, 0.5% Yeast extract, 10mM NaCl,  
(Super Optimal broth with  2.5mM KCl, 10mM MgCl2 , 10mM MgSO4,  
Catabolic Repressor medium) 20 mM Glucose 
Reagent diluent for  ELISA 0.1% (w/v) BSA, 0.05% (v/v) Tween in TBS 
Transfer Buffer 25 mM Tris, 192 mM glycine, 20% methanol 
TAE  40 mM Tris base, 0.1% (v/v) glacial acetic acid,  
(Tris-acetate-EDTA)  Buffer 1 mM EDTA 
TBE 89 mM Tris Base,89 mM Boric Acid,  
(Tris-Borate-EDTA) Buffer 2 mM EDTA 
TE (Tris-EDTA) buffer 10 mM Tris-HCl, 1 mM EDTA pH 8.0, 
2.1.5 Cells 
Cells Description 
HEK293T Human embryonic kidney cells 
Hela Human epithelial carcinoma cell line 
U373-MG Human glioblastoma-astrocytoma, epithelial-like cell line 
1321N1 Human astrocytoma cell line 
2.1.6 Vectors 
Vector Supplier 
pET-30a (+) Novagen 
pRSETA   Invitrogen 
PCMV-HA Clotech 
pcDNA4 Invitrogen 
pMSCV (murine stem cell virus) Clotech  
Vector maps of all plasmids are listed in Appendix I. 
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2.1.7 Animals 
Pellino3 deficient mice and their wild-type littermates were bred at the animal facility at 
the Immunology Institute, National University of Ireland Maynooth. Genotyping was 
performed by PCR analysis of genomic DNA from ear punches as described in 2.2.1 
and genotypes were reconfirmed after the completion of experiments. The mice were 
housed in standard rodent cages, enriched with cardboard housing and nesting material. 
The animals were kept at room temperature (22 – 24°C) in a 12hr light/dark cycle 
(lights on at 8:00 a.m.) with ad libitum access to food and water. All mice were used 
under the guidelines of the Irish Department of Health, and all procedures were 
approved by the research ethics committee of the National University of Ireland 
Maynooth. 
2.1.8 Gifts  
Cell lines: 
HEK293T cells - Prof. Douglas T. Golenbock (The University of Massachusetts 
Medical School, Worcestor, Massachusetts 01605, USA). 
Constructs: 
Pellino3s-flag was from Xiaoxia Li (Cleveland Clinic).  
Myc-RIP1 was from Xin Lin (University of Texas, M.D. Anderson Cancer Center).      
HA-RIP1 and CrmA were from JinWoo Kim (Korea Advanced Institute of Science and 
Technology). 
Caspase-8 (C360/A)-myc and FADD-flag were from A. Thorburn (University of 
Colorado at Denver and Health Sciences Center) 
Chapter two-Material and Methods 
 
44 
2.2 METHODS 
2.2.1 Molecular biological methods 
2.2.1.1 Propagation of DNA 
2.2.1.1.1 Preparation of DNA from E. coli 
TOP10 chemically competent E.coli was used for propagation of plasmids and for the 
cloning of ligation reaction products. 100-400ng of plasmid or a ligation reaction 
product was added to 5μl or 25μl of TOP10 cells, respectively. BL21 competent E.coli 
was used for recombinant protein expression. DNA and the cells were mixed gently 
with a pipette and incubated on ice for 30min. The plasmids were allowed to enter the 
bacterial cells by heat shocking the mixture at 42ºC for 1 min. The cells become 
permeable to allow easy entry of the plasmid and cooling on ice for 2 min makes the 
cells once again impermeable. The transformed cells were then incubated in 150μl SOC 
medium at 37ºC on a Exceller E25 shaker at 220 rpm for 1hr. The mix was then plated 
out on LB agar plates (LB broth with 1.5% (w/v) agar) containing 100μg/ml ampicillin 
or kanamycin antibiotics. Plates were inverted and incubated overnight at 37ºC. Plates 
were then stored at 4ºC for up to four weeks. 
2.2.1.1.1.1 Small scale preparation of DNA from E. coli 
2ml LB broth containing ampicillin (50μg/ml) was inoculated with a single transformed 
E. coli colony from an agar plate. The culture was incubated overnight at 37ºC with 
constant shaking at 220 rpm. Small plasmid preparations were made using the Qiaprep 
Spin Miniprep kit from Qiagen Inc. The bacterial cells were centrifuged at 7,500 g for 
3min and the supernatant was discarded and the plasmid DNA was extracted as outlined 
in the manufacturer‟s handbook. DNA was quantified using a Cary spectrophotometer. 
After diluting the DNA appropriately in TE buffer, the absorbance of the solution was 
measured at 260nm and 280nm. All samples used had an optical density OD260/OD280 
ratio in the range of 1.7 to 1.9. Ratios below 1.7 or above 1.9 indicated RNA or protein 
contamination, respectively. The concentration was calculated according to the 
following relation: OD260=1 corresponds to 50μg/ml of DNA.  
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2.2.1.1.1.2 Large-scale preparation of DNA from E. coli 
A starter culture of LB broth (2ml) containing ampicillin (50μg/ml) was inoculated with 
a single transformed E.coli colony and incubated at 37ºC with shaking at 220 rpm for 6-
8 hr. This was then added to a larger volume of LB broth (100ml) containing the 
relevant antibiotic and incubated at 37ºC overnight with shaking at 220 rpm. Large 
plasmid preparations were made using the Qiagen high-speed plasmid midi kit from 
Qiagen. The bacterial cells were centrifuged at 3,000 g for 25 min and the supernatant 
was discarded and the plasmid DNA was extracted as outlined in the manufacturer‟s 
handbook. DNA was quantified as outlined in Section 2.2.1.1.2.1. 
2.2.1.1.2 Genomic DNA Extraction 
Three week old mice were ear-punched and the tissue placed in sterile tubes.70-100µl 
DirectPCR Lysis Reagent (Tail) (Viagen Biotech) containing freshly prepared 0.2~0.4 
mg/ml Proteinase K was added to the 1.5ml tubes holding the ear punch samples. The 
tubes were incubated at 55°C for 3hr or until no tissue clumps were observed. Crude 
lysates were incubated at 85°C for 45 min. Lysates were stored at -20ºC.  
2.2.1.2 Isolation of RNA and cDNA Synthesis 
2.2.1.2.1 Isolation of total RNA  
In order to minimise RNA degradation, a number of precautions were taken throughout 
the following procedures. All water and salt-based solutions were treated with DEPC 
(0.2%v/v) and then autoclaved. All plasticware was certified RNase-free. Before 
commencing, equipment was wiped with “RNase Zap” an RNase decontamination 
solution. Gloves were worn at all times and regularly changed.  
To confirm the suppression of endogenous expression of Pellino 3, cells were seeded at 
2 x 10
5
 cells/ml in 6-well plates (3ml DMEM/well). Total RNA was extracted from 
cells using Trizol Reagent as per manufacturer‟s instructions. The amount of isolated 
RNA was quantified by measuring the absorbance at wavelengths of 260 nm and 280 
nm on a spectrophotometer, where an absorbance of 1 unit at 260 nm is ~ 40μg/ml. Pure 
RNA preparations have an OD260/OD280 ration of 1.6-1.8. Extracted RNA was stored at 
-80ºC. 
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2.2.1.2.2 Synthesis of first strand cDNA from messenger RNA (mRNA) 
The M-MLV RT 1st-Strand cDNA Synthesis Kit is used for generating full-length first-
strand cDNA from total cellular RNA. 1μg of RNA was placed in nuclease-free 
microcentrifuge tubes and incubated for 10 min at 70ºC. The mixture was then chilled 
on ice and centrifuged briefly. The following components were then added: 
M-MLV RT  (200U/μl) 0.1μl 
dNTPs (10mM) 1μl 
5 x M-MLV Buffer 2μl 
MgCl2 (25mM) 2μl 
RNasin (40U/μl) 0.25μl 
Random Primers (0.5μg/μl) 1μl 
Nuclease-Free Water to 10μl 
The reaction mixture was incubated for 10 min at RT allowing the primers to anneal to 
the RNA. Next, the reaction was incubated at 42°C for 30 min. M-MLV RT was then 
deactivated by heating to 95
o
C for 5 min followed by cooling to 4
o
C for 5 min. 
Generated cDNA was stored at 4ºC for short-term storage or -20
o
C for long-term 
storage. 
2.2.1.3 Expression plasmid construction 
2.2.1.3.1 PCR Amplification 
PCR products were amplified using either cDNA or plasmid DNA as template. The 
primers were designed based on deposited GenBank sequences. Each forward and 
reverse primer contained a restriction site, thereby flanking the gene. Proteins were 
tagged at either the amino- or carboxy-terminus by incorporating the appropriate 
epitope tag sequence into the forward or reverse primer, respectively (see Appendix I 
Table I for details of primer sequences, restriction sites used). The GC-RICH PCR 
System, which contains a mixture of Taq polymerase and Tgo proofreading polymerase, 
was used for the amplification of PCR products. The standard PCR conditions below 
were used to amplify the target sequence: 
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Template (50ng plasmid DNA) 2μl 
5X Enzyme Buffer 10μl 
GC-Rich Resolution Solution 2.5μl 
MgCl2 5μl 
Primers (10pmol/μl) 2.5μl each 
dNTP mix (10mM each) 4μl 
Enzyme mix 1μl 
PCR-grade water to 50μl 
Each reaction was initially heated to 94ºC for 5 min. This was followed by 35 cycles of 
94ºC for 30 s, 52ºC for 30 s, and 72ºC for 2 min. Samples were then incubated at 72ºC 
for 10 min and stored at 4ºC if necessary.  
2.2.1.3.2 Agarose gel electrophoresis 
Agarose gels were prepared by suspending agarose in TAE. This was heated in a 
microwave until the agarose had completely dissolved, and was then cooled to less than 
50ºC. Ethidium bromide (5μg/ml) was added and the agarose poured into the gel tray. 
Following solidification, agarose gels were covered and electrophoresed in TAE (1X). 
Samples were mixed with loading dye. Samples were run simultaneously with 
molecular size markers, with the range of ladder chosen to suit the particular sample 
size. The voltage at which gels were run depended on the particular application. Nucleic 
acids were visualised under ultraviolet (UV) light (254nm) and images acquired using 
the Syngene G box gel documentation system (Frederick, MD, USA). 
2.2.1.3.3 Preparation of insert and vector DNA 
PCR product was electrophoresed on a 1% low melting TAE agarose gel at 100V for 1h. 
The gel was placed on an UV transilluminator box and the DNA band of correct size 
was excised using a scalpel, and placed in a 1.5ml microcentrifuge tube. DNA was 
extracted from the gel using the QIAquick Gel Extraction Kit, according to the 
manufacturer‟s instructions. DNA was eluted in a volume of 40μl and constituted insert 
for the following cloning procedure.  
Both insert DNA and vector were digested overnight at 37ºC with 30U each of the 
required restriction enzymes, using recommended reaction buffers. DNA was 
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electrophoresed in a 1% TAE agarose gel, before excision and gel purification using the 
QIAquick Gel Extraction Kit. 
Both insert and vector DNA was electrophoresed in a 1%TAE agarose gel alongside a 
quanti-ladder in order to gauge the concentration of insert and vector for subsequent 
ligation reactions. 
2.2.1.3.4 Ligation of insert and vector 
A ligation reaction was performed with the ratio of insert to vector determined by their 
concentration and size. 100ng of vector was used and the amount of insert required was 
calculated as follows: 
Quantity of Vector (100ng) x Size of Insert  x 3  = ng Insert 
Size of Vector 
Each ligation reaction consisted of vector DNA, insert DNA, Clonables™ 2X Ligation 
Premix, and the total volume (5μl) was made up. The reaction was incubated at 16ºC for 
20 min. The ligation reaction mix was then used to transform competent E.coli cells. 
Plasmid DNA was then purified from colonies and sequenced by MWG Biotech to 
confirm the fidelity of PCR amplification and the correct insertion of DNA insert into 
the vector. 
2.2.1.4 PCR-based genotyping 
PCR amplification was performed on genomic DNA using GotoTaq DNA polymerase 
and specific primers to detect heterozygous/homozygous conventional alleles: 
2092_25: CCCAACATAGGTGTTTCCTCTCC -  
2092_29: GTGCATACACATTCATGCAAGC -  
2091_27: GACACGTGTGGAGATAATGAGG -  
2091_28: ACCCAGGCACAAGTCAAGC - 
control primers: 
1260_1: GAGACTCTGGCTACTCATCC - 
1260_2: CCTTCAGCAAGAGCTGGGGAC - 
Cre transgene Primers: 
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1011_1: Cre_tot1_ACGACCAAGTGACAGCAATG -  
1011_2: Cre_tot2_CTCGACCAGTTTAGTTACCC - 
Reaction: 
Template 2μl 
5 xBuffer 5μl 
MgCl2 2μl 
Primers (10pmol/μl) 2.5μl each 
dNTP mix (10mM each) 1μl 
GotoTaq 0.15μl 
PCR-grade water to 25μl 
For each target the samples were initially heated to 94°C for 5 min. This was followed 
by 35 cycles at 95°C for 30s, at 60°C for 30s and at 72°C for 1 min. Samples were then 
incubated at 72°C for 10 min and stored at 4°C. The PCR products were subjected to 
electrophoresis on a 2% (w/v) TAE agarose gel, containing 5μg/ml ethidium bromide. 
2.2.1.5 Real time PCR 
Reverse Transcription was carried out as described in section 2.2.1.2. Primer sequences 
used to amplify the fragments of the indicated genes are described in the Appendix I 
Table II. 
A 20μl real-time PCR reaction mixture was prepared in each optical tube as following: 
Template (50ng plasmid DNA) 2μl 
Master Mix (2x) 10μl 
Primers (10pmol/μl) 1μl each 
PCR-grade water to 20μl 
For each target the samples were initially heated to 95°C for 15 min for predenaturation. 
This was followed by 40 cycles at 95°C for 30s, at 60°C for 30s and at 72°C for 30s. 
Integration of the fluorescent SYBR Green into the PCR product was monitored after 
each annealing step. Amplification of one specific product was confirmed by melt curve 
analysis where a single melting peak eliminated the possibility of primer-dimer 
association. For melting curve analysis to be performed the products were heated from 
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60°C to 95°C after the 40 cycles. The PCR were conducted in a Bio-Rad ICycler real-
time PCR instrument. The relative quantification of target genes expression was 
evaluated using the ∆∆CT method. Crossing Threshold (Oshima et al.), which recorded 
the cycle when sample fluorescence exceeds a chosen threshold above background 
fluorescence, was generated by Bio-Rad ICycler software. The ∆CT value was 
determined by subtracting the HPRT CT value for each sample from the target CT value. 
Fold change in the relative gene expression of target were determined by calculating the 
2 
−∆CT
. 
2.2.2 Cell Biological Methods 
2.2.2.1 Cell Lines  
Hela, HEK293T, U373 and 1321N1 cells were cultured in Dulbecco‟s modified Eagle‟s 
medium supplemented with 10% (v/v) fetal bovine serum, 100μg/ml penicillin G, and 
100μg/ml streptomycin. Cells were maintained at 37°C in a humidified atmosphere of 5% 
CO2. Cells were passaged every 2 to 3 days using 1% (w/v) Trypsin/EDTA solution in 
PBS.  
2.2.2.2 MEF cells 
For the preparation of primary MEFs, Pellino3
+/– 
mice were intercrossed to produce 
Pellino3
+/+ 
and Pellino3
–/–
 embryos. Mouse breeder pairs were set up in the afternoon 
with one male being set up with two or three virgin 7-8 week old females. Females were 
checked for copulatory plugs the following morning. If present, this was marked as day 
+0.5 (or rounded off to day +1).  Females, with copulatory plugs, were removed from 
the male‟s breeder cages.  The remaining females were checked on a daily basis.  
E13.5-timed pregnant mice were euthanized according to standard protocols. The uterus 
(containing the embryos) was cut free from the mouse and placed in a sterile petri dish. 
Embryos were removed from the uterus one at a time in sterile PBS under sterile 
conditions in a laminar flow hood. The head and all of the soft tissues from each 
embryo were removed under a dissecting scope so that only the carcasses were left. 
Embryo carcasses were minced using small scissors, and then washed with 2-3 times 
with PBS 2-3 in 15ml conical tubes. Enough trypsin-EDTA solution was added to just 
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cover each minced carcass. The mixture was then incubated at 37ºC for 15 min. MEF 
media (10ml) was then added to the conical tubes. The tissue was dissociated into single 
cells by vigorous pipetting. The digested tissue was passed through a 70µM cell strainer 
to get rid of un-dissociated tissue clumps. The cells that flowed through the cell strainer 
were washed once with fresh MEF media, and cells from each embryo were plated to 
individual 175cm
2
 flasks. MEF cells were passaged every 3-4 days or until they were 
confluent. DNA samples were collected from discarded head or soft tissue for 
genotyping. It was necessary to dilute the DNA because of the large amount of DNA 
and the possibility of maternal blood contamination. 
2.2.2.3 Transient Transfection  
2.2.2.3.1 Transfection of cells for overexpression studies 
Cells were seeded at 2x10
5
 cells/ml in 6-well plates (3ml DMEM/well). Cells were 
grown for 24 hr to approximately 70% confluency. For each well of a 6-well plate to be 
transfected, DNA (amount depending on individual assays as outlined in relevant 
sections) was diluted in 250μl OptiMEM and mixed gently. 4μl Lipofectamine 2000 
was then diluted in 250μl OptiMEM and incubated at room temperature. After 5 min 
incubation, the diluted DNA was combined with the diluted Lipofectamine 2000, mixed 
gently, and incubated at room temperature for 20 min. 1ml of medium was removed 
from each well before adding the DNA-Lipofectamine complexes (500μl). 
2.2.2.3.2 Transfection of cells for Knockdown studies 
Pellino3-specific siRNA (Sense: 5‟-GCACAGCAUCUCGUAUACATT-3‟; Antisense: 
5‟-UGUAUACGAGAUGCUGUGCTG3-‟) was from Ambion and cells were 
transfected by Lipfectamine2000 (see section 2.2.2.3) and allowed recover for 48 hr 
prior to experiments. 
2.2.2.4 Lentiviral ShRNA Infection  
2.2.2.4.1 Lentiviral production 
HEK293T cells were seeded at 2x10
5
 cells/ml in 6-well plates (3 ml /well) and grown 
for 24 hr  to approximately 70% confluency. The cells were transfected as described in 
section 2.2.2.3.1 with a DNA mixture containing packaging plasmid dR89.1 (900ng), 
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envelope plasmid VSV-G (100ng) and Pellino3-shRNA (1μg). The human Pellino3 
shRNA had the following sequence:. 
5‟GCACTTGCTGATAGCCACTATCCGGGCACTTGCTGATAGCCACTATCTCGA
GATAGTGGCTATCAGCAAGTGCTTTTTTG. -3‟ 
A control shRNA was also used in the transfection. It was a non-targeting shRNA 
vector that can activate the RNA-induced silencing complex and the RNAi pathway, but  
does not target any human or mouse genes. To remove the transfection reagent, the 
media was changed 24 hr post-transfection and replaced with fresh high serum (30%) 
growth media. The cells were then incubated for 24 hr. The media containing lentivirus 
were harvested 48h post-transfection and transferred to a polypropylene tube for storage 
at -20°C. The media was replaced with fresh high serum (30%) growth media and the 
cells were incubated for further 24 hr. The virus was harvested one more time and after 
the final harvest the packaging cells were discarded. 
2.2.2.4.2 Lentiviral infection 
Hela, HEK293T, U373 and 1321N1 cells were seeded at 2x10
5 
cells/ml in 6-well plates 
(3ml/well medium). The cells were left to recover for a few hours and then infected with 
600μl of virus-containing conditioned media. Polybrene (8μg/ml) was added to improve 
transduction efficiency. The plates were incubated at 37ºC. The media was removed 24 
hr post-infection and replaced with fresh growth media containing puromycin (10μg/ml) 
to select for cells transduced with shRNA. The polyclonal population of cells were 
cultured for one week before suppression of Pellino3 expression was determined. The 
knockdown efficiency was assessed by immunoblotting of whole cell lysates. 
2.2.2.5 Retroviral rescue assay 
MSCV plasmid or MSCV-mPellino3 (mP3), MSCV-mP3FHAm or MSCV-mP3Em 
(1μg) were co-transfected with the packaging vector φ (1μg) into 293T cells. After 48 hr, 
the retrovirus-containing medium was harvested and used to infect Pellino3-deficient 
MEFs in 25 cm
2
 flasks. The flasks were incubated at 37°C for 48 hr prior to 
experiments. 
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2.2.2.6 TUNEL staining and confocal microscopy  
Transfected cells were treated as indicated in Figures, then fixed in 4% (w/v) 
paraformaldehyde for 15 min and stained with TUNEL and Hoechst 33342 using the 
DeadEndTM fluorometric TUNEL system according to manufacturer‟s instruction. 
Confocal images were captured using the Χ40 objective on the Olympus Fluoview 
System laser scanning microscope equipped with the appropriate filter sets and analyzed 
using Photoshop8.0 and SPOT3.5 software (supported by Ilona Dix). 
2.2.2.7 MTT assays 
Pellino3 knockdown cells were grown in 48-well plates and then stimulated with TNFα 
(40ng/ml) and CHX (10µg/ml) or CHX alone for indicated times.  MTT (5mg/ml) was 
added to the cells and incubated for 3 hr at 37°C. Media was removed and DMSO added 
to dissolve the cells. The absorbance of the solubilised material was measured at 540nm 
using a BioTEK microplate reader and this was used as an index of mitochondrial 
activity and thus cell viability. 
2.2.3 Biochemical methods 
2.2.3.1 Western blot analysis 
2.2.3.1.1 Preparation of samples 
The harvesting of whole cell extracts was carried out at 4ºC. Medium was removed 
from cells and the cells were then washed once in PBS before adding lysis buffer to 
each well. The plate was placed on a rocker for 30 min at 4ºC. The lysates were then 
scraped into 1.5ml microcentrifuge tubes and centrifuged at 12,000 x g for 10 min. The 
supernatants were removed to new 1.5ml microcentrifuge tubes. Extracts were boiled 
for 5 min in sample buffer, briefly centrifuged at 4ºC and stored at -20ºC 
2.2.3.1.2 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Samples and appropriate prestained (26.6-180kDa) protein markers were loaded into 
separate wells. Electrophoresis was performed at 80V through a 5% SDS 
polyacrylamide stacking gel and then through a 7-15% SDS polyacrylamide resolving 
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gel at 120V for 1.5~2 hr. The percentage gel was chosen based on the size of the 
proteins being electrophoresed. 
2.2.3.1.3 Immunoblotting 
Following separation by electrophoresis, the proteins were transferred 
electrophoretically to nitrocellulose membranes in a Hoefer TE 70 Semiphor semi-dry 
transfer unit at 110mA for 1.25 hr using Whatmann and nitrocellulose pre-soaked in 
cold transfer buffer for 10 min. Following transfer, non-specific binding was blocked by 
incubating the nitrocellulose membranes at room temperature for 1 hr (or overnight) in 
blocking Buffer. The membranes were then incubated at 4ºC overnight with the primary 
antibodies diluted in TBST containing 5% (w/v) skimmed milk powder or BSA, optimal 
dilutions of primary as indicated on datasheet. The membranes were subsequently 
subjected to 3 x 10 min washes in TBST prior to incubation with secondary antibody 
specific for the primary antibody in question (anti-rabbit or anti-mouse) in TBST 
containing 5% (w/v) skimmed milk powder for 1hr in the dark at room temperature. The 
membranes were then washed a further 3 times for 10 min each in TBST in the dark. 
The immunoreactive bands were detected using Odyssey infrared imaging system from 
Licor Biosciences, according to the instructions of the manufacturer.   
2.2.3.2 Co-immunoprecipitation (CoIP) 
2.2.3.2.1 Co-IP analysis of overexpressed proteins 
Cells were transfected with Lipofectamine2000 as previously described in section 
2.2.2.3 at a 1:1 ratio of expression constructs. Cell extracts were generated as previously 
described in section 2.2.3.1.1. Cell lysates were initially precleared by incubating with 
non immune IgG antibody (1μg) and protein A/G-agarose (10μl) for 1hr at 4°C with 
rocking followed by rapid centrifugation of the agarose beads. Each supernatant was 
removed to a fresh microcentrifuge tube followed by addition of the appropriate 
antibody (2μg) and incubated for 24 hr at 4°C with rocking. An aliquot (50μl) of protein 
A/G agarose was added to each sample and incubated with rocking overnight at 4°C. 
Samples were added to chilled spin columns and centrifuged at 16,000 g for 1 min. The 
beads were washed with CoIP lysis buffer (500μl) and subject to re-centrifugation. This 
step was repeated 3 times. The columns were moved to fresh tubes and 60μl of SDS-
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PAGE sample buffer was added to the columns for 20 min at room temperature. 
Samples were centrifuged at 16,000g for 2 min, to elute immunocomplexes and 
subsequently boiled at 100ºC for 5 min and analyzed using SDS polyacrylamide gel 
electrophoresis and Western blotting (section 2.2.3.1). 
2.2.3.2.2 Co-IP analysis of endogenous proteins 
For DISC complexes analysis, cells were stimulated for various times with TNFα 
(40ng/ml), CHX (10μg/ml) and Z-VAD-FMK (20μm) and then were lysed for 
immunoprecipitation and Western immunoblotting analysis as described above. 
2.2.3.3 In vitro binding assay 
2.2.3.3.1 Expression and purification of 6×his-tagged proteins 
Plasmid DNA (1µl) was transformed into competent E .coli strain BL21 cells as 
described in section 2.2.1.1. 25ml LB broth, containing the appropriate antibiotics, was 
inoculated with a single transformed colony and grown overnight at 37°C. 10ml aliquot  
of this pre-culture was used to inoculate 1L of LB, containing the appropriate antibiotics, 
and incubated at 37°C up to the logarithmic phase of growth (OD600 reaches 0.6~0.8). 
Protein expression was then induced by overnight treatment at 15°C with IPTG 
(100µM). The bacteria were pelleted by centrifugation of 6,000 g for 15 min at 4°C, and 
resuspended in 25ml native lysis buffer. Three cycles of freeze-thawing and sonication 
were performed on the lysates to completely lyse the bacteria. The lysates were cleared 
by centrifugation at 10,000 g for 30 min. 0.8ml Ni-NTA resin was washed three times 
with wash buffer, then added to the cleared lysates, and incubated at RT for 2 hr with 
constant rotation. The Lysates-Ni-NTA mixture was loaded into a gravity flow column. 
Trapped resin was washed three times with 10ml wash buffer. Protein was eluted in 5ml 
Elution Buffer. Protein purity was determined by SDS-PAGE analysis (with Coomassie 
Blue G250 staining). 
2.2.3.3.2 In vitro binding assays 
Recombinant myc-tagged Pellino3 proteins (1μg) were initially immunoprecitated in 
binding buffer using an anti-myc antibody (2µg) and proteinA/G beads (30µl) as above. 
The beads were washed 5 times with binding buffer and then incubated overnight at 4°C 
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with lysates (300µl from 6 well plates) from HEK293T cells previously transfected with 
HA tagged RIP1. Beads were subjected to serial washes with binding buffer followed 
by centrifugation. Co-precipitated proteins were eluted in SDS-PAGE sample buffer 
and then subjected to Western blot analysis. 
2.2.3.4 EMSA 
EMSA was used to detect the presence of DNA-binding proteins in nuclear extracts. 
NF-κB Infrared Dye labelled oligonucleotides was purchased from Licor Biosciences. 
2.2.3.4.1 Preparation of sub-cellular fractions 
Following treatment, cells were washed with 1 ml of ice cold PBS and then scraped into 
hypotonic Buffer-A (1ml). Following centrifugation at 4ºC, (21,000 g for 10 min) the 
supernatants were removed and the cells were lysed for 10 min on ice in Buffer-A 
containing 0.1% (w/v) Igepal (20μl). Lysates were centrifuged at 21,000 g for 2 min. 
The resulting supernatants constituted cytosolic extracts and were stored at -20ºC in 
fresh microcentrifuge tubes. The remaining pellets were resuspended in 20μl of Buffer-
C and incubated on ice for 15 min. Incubations were then centrifuged at 21,000 g for 10 
min. The supernatants were then transferred to 75μl of Buffer D. Such samples 
constituted nuclear extracts. Protein concentrations were determined by the method of 
Bradford and assayed for NF-κB-DNA binding activity as outlined in the following 
section. 
2.2.3.4.2 EMSA reaction 
Nuclear extracts (5μg of protein), generated as described in section 2.2.3.4.1, were 
incubated with the following reaction mix: 
10x Binding Buffer  2μl 
Poly (dI-dC)  1μl 
25mM DTT 2μl 
1% NP40 1μl 
1mM MgCl2 1μl 
NF-κB IRDye labelled oligonucleotides 1μl 
 8μl 
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Nuclear extracts (5 μg of protein) … 
Water to 20μl 
NF-κB consensus oligonucleotide: 
 5‟ - AGTTGAGGGGACTTTCCCAGGC - 3‟ 
 3‟ - TCAACTCCCCTGAAAGGGTCCG - 5‟ 
 Underlined nucleotides are the binding site  
For competition assays, unlabeled oligonucleotides containing the consensus NF-κB 
were added for 20 min at room temperature, prior to addition of the IRDye labelled 
oligonucleotides. Incubations were performed in the dark for 1hour at room temperature. 
Poly (dI-dC) was added to prevent non-specific binding of proteins to the NF-κB, 
oligonucleotide probe and thereby to reduce background. 
2.2.3.4.3 Preparation of native polyacrylamide gel 
A native 5% Acrylamide Gel was prepared as follows 
H2O 39ml 
10x TBE 2.5ml 
30% Polyacrylamide 8.4ml 
10% APS 250μl 
TEMED 20μl 
The components were mixed well while minimizing bubble formation.  The gel was 
poured and allowed polymerize for 30-45 min. The gel was pre-run in 0.5X TBE for 30 
min at 90V.  
2.2.3.4.4 Electrophoresis 
Following incubation of reaction, orange loading dye (2μl) was added and the 
incubations were then subjected in the dark to electophoresis for 90 min at 90V in a 
non-denaturing 4% (w/v) polyacrylamide gel. Gels were run in 0.5 x TBE buffer. Gels 
were then removed from the glass plates and visualised using Odyssey Infrared Imaging 
System from Licor Biosciences.  
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2.2.3.5 ELISA 
Samples were collected and stored at -20ºC until ELISA analysis. 96-well NUNC 
“Maxisorb” plates were coated with mouse anti-human IL-8 capture antibody (4μg/ml) 
and were incubated overnight at room temperature. Plates were washed three times with 
wash buffer (PBS with 0.05% (v/v) Tween-20) and dried by inverting the plates on 
tissue paper. Plates were blocked for 1 hr with PBS containing 1% (w/v) BSA. Plates 
were again washed three times and dried. Samples or standards (100μl) diluted in 
reagent diluent were added to each well. The concentrations of standards were between 
0 and 2000pg/ml. Plates were incubated with samples or standards for 2 hr and then the 
series of washes was repeated. Detection antibody (100μl) (biotinylated sheep anti-
human antibody) diluted in reagent diluent was added to each well (40ng/ml). Again 
plates were incubated for 2 hr and washed. Streptavidin-HRP conjugate (100μl) was 
added to each well. The plates were incubated in the dark for 20 min and then the wash 
step was repeated. 100μl TMB (1.25mM/l) solution was added to each well and again 
plates were incubated in the dark for no longer than 20 min. 50μl 1 N H2SO4 was used 
to stop the reaction and the OD was measured for each well at 450nm and 590nm using 
a ELx800TM microplate reader with Gen5 Data Analysis Software. The concentrations 
of IL-8 in each sample were extrapolated from a standard curve that related the OD of 
each standard amount to the known concentration. Standard samples were assayed in 
duplicate to generate the standard curve, while all samples were assayed in triplicate. 
2.2.4 Animal experiments  
For liver toxicity induced by TNF and D-Gal, age and sex-matched wild type and 
Pellino3-deficient mice were injected intraperitoneally with TNF (0.0025µg/g body 
weight) plus D-Gal (0.8mg/g body weight). Mouse survival was monitored within 36 hr, 
after which no further deaths occurred. Liver samples were collected at 12 hr after 
injection. Serum samples were obtained at 7 hr after treatment.  
2.2.5 Immunohistochemical analysis  
The samples of liver tissue were fixed in neutral buffered formalin. Following fixation 
tissues were paraffin embedded, sectioned at 5μm and stained with haematoxylin and 
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eosin (H&E). For detection of cleaved caspase-3, sections were deparaffinized and 
incubated in 0.3% (v/v) H2O2 for 30 min for blockade of endogenous peroxidase 
activity and then blocked with PBS containing 5% (v/v) goat serum and finally 
incubated with anti-cleaved caspase-3. The Vectastain ABC kit was used according to 
the manufacturer‟s specifications for immunoperoxidase systems. Peroxidase activity 
was visualized with ImmPACT™ DAB (Aragay et al.). The nuclear counterstain was 
stained by HEMATOXYLIN (Blue). Staining was viewed with an E-800 Eclipse 
microscope (Nikon). 
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CHAPTER THREE: RESULTS 
TNF is a proinflammatory cytokine that can regulate cell proliferation, differentiation 
and death. Exposure of cells to TNF can activate the TNFR signalling pathway, 
inducing cell survival by activating NF-κB or cell death through apoptosis / necroptosis 
(Scaffidi et al., 1999; Galluzzi and Kroemer, 2008). Binding of TNF to its receptor 
initiates the formation of complex I, a multi-component complex containing TRADD, 
RIP1, TRAF2 and TRAF5, which is responsible for mediating the activation of the NF-
κB and JNK pathways (Chen and Goeddel, 2002; Hsu et al., 1996). RIP1 plays an 
essential role in the activation of NF-κB. TNF-induced K63-linked polyubiquitination 
of RIP1 facilitates the recruitment of the IKK complex by virtue of the ubiquitin-
binding domain of IKKγ (Ea et al., 2006). The polyubiquitinated RIP1 also recruits 
TAK1 via the ubiquitin-binding domains of TAK1-associated proteins termed TABs, 
thus allowing TAK1 to phosphorylate and activate IKK (Chen, 2005; Ishitani et al., 
2003; Wang et al., 2001). NF-κB exists in all cells in a resting state in the cytoplasm 
and is activated only in response to stimuli. Under resting condition, NF-κB is 
sequestered in an inactive form by unphosphorylated IκBα. In response to extracellular 
signals such as TNF, IκBα is phosphorylated by the IKK complex, leading to its 
ubiquitination and degradation, allowing for NF-κB to translocate into the nucleus and 
trigger the transcription of a series of target genes (Zandi et al., 1997).  
Whilst NF-κB is a key pro-inflammatory transcription factor it can also enhance cell 
division and inhibit apoptosis in response to harmful stimuli. It is responsible for 
protecting cells from TNF-induced apoptosis by activating anti-apoptotic genes, such as 
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XIAP (Eckelman et al., 2006), cIAP1/ cIAP2 (Rothe et al., 1995), and cFLIP (Krueger 
et al., 2001). 
In response to certain stimuli, Complex I is released from TNFR1 and recruits FADD 
and procaspase-8, to form an “apoptotic complex” (DISC), leading to apoptosis 
(Micheau and Tschopp, 2003; Wang et al., 2008). The formation of DISC is tightly 
regulated to keep the balance between survival and death in cells. A series of 
prosurvival genes under direct NF-κB control, such as cFLIP1, cIAP1, cIAP2, Bcl-x, 
XIAP  (Micheau et al., 2001; Mahoney et al., 2008; Tao et al., 2006; Dutta et al., 2006) 
can inhibit caspase-8 binding to FADD, blocking the activity of DISC. This inhibition is 
relieved through either degradation of these prosurvival proteins or termination of the 
NF-κB transcriptional activity (Wang et al., 1998; Chang et al., 2006; Micheau et al., 
2001). The K63 polyubiquitination of RIP1 is a key determining factor in these 
pathways since its ubiquitination biases the TNF pathway towards activation of NF-κB 
and the induction of anti-apoptotic genes (Hayden and Ghosh, 2008). 
The mammalian Pellino family is comprised of 4 family members, Pellino1, Pellino2 
and two spliced variants of Pellino3 (Pellino3s and 3l) (Moynagh, 2009; Schauvliege et 
al., 2007). Each member of the family contains an N-terminal  FHA domain，a 
phosphothreonine-binding module that facilitates interaction with IRAKs (Lin et al., 
2008) and a C-terminal RING-like domain that catalyses K63 polyubiquitination of 
IRAKs (Butler et al., 2007; Ordureau et al., 2008; Schauvliege et al., 2006). IRAKs are 
key signalling intermediates the IL-1 and the TLR pathways and thus Pellino proteins 
are implicated in these signalling cascades. In a previous study, Chang and colleagues 
identified Pellino1 as an E3 ubiquitin ligase for RIP1 in the TLR3/TLR4 pathways, 
suggesting that Pellino proteins may be able to regulate TNF signalling. The major 
focus of this thesis was to investigate whether Pellino3 is involved in TNF signalling 
pathway and to identify the molecular mechanisms involved. 
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3.1 Pellino3 knockdown sensitizes cells to the pro-apoptotic effects of 
TNF. 
To investigate the potential role(s) of Pellino3 in regulating TNF signaling, Hela cells, 
that display stable suppression of Pellino3, were generated using Pellino3-specific 
shRNA. Pellino3 expression was measured at the mRNA level and this approach 
confirmed that Pellino3 expression was reduced by 55% in cells selected for stable 
integration of Pellino3-specific shRNA (Figure 3-1A). TNF is well known to cause cell 
death in the presence of protein synthesis inhibitors by virtue of the latter preventing the 
induction of anti-apoptotic proteins. In this study, cells were treated with TNF and CHX, 
a well known protein synthesis inhibitor, which enhances the sensitivity of tumor cells 
to the cytotoxic effects of TNF (Vassalli, 1992). The combined treatment of Hela cells 
with TNF (40ng/ml) and CHX (10μg/ml) caused the cells to become rounded and non-
adherent but the number of such cells was greatly increased when Pellino3 expression 
was suppressed by Pellino3-specific shRNA (Figure 3-1B). To quantify cell viability, an 
MTT assay was performed. This is a rapid, precise and simple method that measures 
mitochondrial activity based on the absorbance of the dissolved MTT formazan crystals 
formed in living cells (Mosmann, 1983). The MTT-based viability assay revealed that 
the morphological changes, observed in Pellino3 knockdown cells were associated with 
reduced cell viability. Thus the combined treatment of TNF and CHX caused a 50% 
reduction in cell viability in Pellino3 knockdown cells, whereas the co-treatment 
reduced viability by 20% in control cells (Figure 3-1C).  
Since TNF can induce cell death via caspase activation as well as by necroptosis, it was 
necessary to investigate the type of death induced in Pellino3 deficient cells. To this end 
a FACS-based approach measuring Annexin V staining was conducted. Annexin V can 
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bind to phosphatidylserine that is exposed on the outer leaflet of the plasma membrane 
and this is a key feature of early apoptosis (Koopman et al., 1994). Knockdown of 
Pellino3 expression caused greatly enhanced Annexin V staining of Hela cells when co-
treated with TNF and CHX, compared with cells infected with lentivirus containing 
control shRNA (Figure 3-1D). After exposure with TNF plus CHX the percentage of 
Pellino3 shRNA-infected cells with positive staining of Annexin V was approximately 
45%, while 23% of control cells showed positive staining. There was no difference 
observed in Annexin V staining of control and Pellino3-knockdown cells that had been 
exposed to CHX alone. In order to further confirm that the increased cell death in 
Pellino3-knockdown cells was apoptotic in nature the sensitivity of cell death to Z-
VAD-fmk was assessed. The latter has the ability to inhibit apoptotic cell death by 
inhibiting the upstream activator caspase-8 (Sun et al., 1999). The level of apoptosis in 
Pellino3-knockdown cells was reduced to control levels of 14% by treatment of cells Z-
VAD-fmk further confirming that knockdown of Pellino3 promotes the ability of TNF 
to induce caspase-dependent apoptosis (Figure 3-1D). 
Apoptosis is also associated with the cleavage of a number of intracellular proteins 
including caspase-8, caspase-3 and PARP. The activation of caspase-8 leads to the 
generation of the active p18 and p10 subunits, which have the ability to cleave and 
activate the executioner caspases, such as caspase-3, -6, -7, leading to apoptosis (Muzio 
et al., 1996). Caspase-3 is cleaved to release the active 17 kD and 12 kD subunits, 
ultimately eliciting DNA fragmentation and cell shrinkage (Tewari et al., 1995). PARP, 
which is 113 kDa nuclear chromatin-associated enzyme involved in DNA repair process 
is also a classical caspase substrate and upon caspase activation is cleaved into two 
fragments of approximately 89 kD and 24 kD (Margolin et al., 1997). Thus the cleavage 
status of caspase-8, caspase-3 and PARP was examined in Pellino3 knockdown cells in 
response to TNF and CHX treatment to further validate the apoptotic nature of the cell 
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killing in these cells (Figure 3-2). The combined treatment of TNF and CHX caused a 
time-dependent increase in the levels of cleaved caspase-8, caspase-3 and PARP but the 
levels were greatly increased in Pellino3 knockdown cells. In combination with the 
earlier data these findings clearly indicate that reduced Pellino3 expression sensitizes 
Hela cells to the pro-apoptotic effects of TNF. 
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Figure 3-1 Knockdown of Pellino3 expression enhances the pro-apoptotic effects of TNF in Hela 
cells. 
Hela cells were infected with lentivirus containing constructs that encoded control or human Pellino3-specific shRNA. 
Cells were grown in the presence of puromycin to select for cells showing stable integration of shRNA constructs. (A) 
RNA was extracted from cells 48 hr post transfection and analysed by quantitative RT-PCR for levels of Pellino3 
mRNA. Data are presented relative to cells transfected with lamin A/C-siRNA and represent the means +/- S.D. of 3 
independent experiments. (B,C,D) Selected cells were treated in the absence (control) or presence of human TNF 
(40ng/ml), CHX (10μg/ml) or the caspase inhibitor zVAD-fmk (20μM) for 5 hr or other indicated times. (B) Cells 
were photographed using a phase contrast microscope (bar 20μm). (C) Cells were analyzed for cell viability using 
MTT assays with viability expressed relative to control shRNA-infected cells treated with CHX alone. (D) Cells were 
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analyzed by flow cytometry for percentage of cells staining positive for Annexin V staining. Data represent the mean 
+/- S.D. of 3 independent experiments. ***p<0.001.   
 
Figure 3-2 Immunoblot analysis of apoptotic marker proteins in Pellino3 knockdown Hela cells.  
Hela cells were infected with lentivirus containing constructs that encoded control or human Pellino3-specific shRNA. 
Cells were grown in the presence of puromycin to select for cells showing stable integration of shRNA constructs. 
Selected cells were treated in the absence (0) or presence of human TNF (40ng/ml) plus CHX (10μg/ml) for indicated 
times. Cell lysates were subjected to 10–15% SDS-PAGE and probed by immunoblotting for expression levels of 
PARP, cleaved caspase-3, caspase-8, Pellino3 and β-actin. Cleaved forms of PARP and caspase-8 are indicated by 
arrows. 
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3.2 Suppression of pellino3 enhances TNF-induced apoptosis in a 
manner independent of NF-κB and MAPK signalling. 
After binding to TNFR1, TNF can activate NF-κB, which is a well-known transcription 
factor that has ability to upregulate anti-apoptotic proteins (Chen and Goeddel, 2002). 
Activation of the MAPKs, p38 and JNK is also known to regulate apoptosis, while the 
ERK pathway activity is suppressed by JNK/p38 kinases during apoptosis induction 
(Junttila et al., 2008). Given such regulatory roles of the NF-κB and MAPK pathways in 
regulating apoptosis, the effects of Pellino3 knockdown on the ability of TNF to trigger 
these pathways was next examined in an effort to increase our understanding of the 
molecular basis to pro-apoptotic effects associated with Pellino3 knockdown. Since the 
activation of NF-κB requires the prior phosphorylation and degradation of its inhibitory 
protein IκBα, the levels of IκBα were initially measured as an indirect index of 
activation of the NF-κB pathway.  
In Hela cells infected with Pellino3 shRNA the early phase of TNF-induced degradation 
of IκBα was still evident, but less IκBα was apparent at the later time points, suggesting 
that knockdown of Pellino3 may prolong the temporal profile of NF-κB activation 
(Figure 3-3 A).  
In order to directly measure the effects of Pellino3 knockdown on NF-κB activity, 
nuclear extracts were prepared from cells and assayed by EMSA analysis for binding to 
fluorescently labelled oligonucleotides containing the NF-κB consensus motif. Basal 
NF-κB-DNA complexes were present in extracts from unstimulated cells while a 
complex of slower electrophoretic mobility was evident in extracts from TNF-
stimulated cells (Figure 3-3B). Suppression of endogenous Pellino3 with shRNA led to 
an increase in the formation of the upper complexes following TNF stimulation, 
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compared to control shRNA. The enhanced levels were apparent at 25 min post TNF 
stimulation but the activation of NF-κB in response to TNF was more sustained in 
nature, with the activation still much higher at 60 min post TNF stimulation in cells 
infected with Pellino3 shRNA. NF-κB-DNA complexes were judged to be specific 
based on their sensitivity to the unlabelled oligoncleotide containing the NF-κB binding 
motif (see first lane in Figure 3-3B). The EMSA analysis in conjunction with the IκBα 
analysis is consistent with a role for Pellino3 in terminating TNF-induced activation of 
NF-κB. 
The effect of Pellino3 knockdown on TNF-induced MAPK activation was next 
examined. Exposure of Hela cells to TNF caused increased phosphorylation of JNK, 
P38 and ERK that peaked by 15-30 min in both control and Pellino3 knockdown Hela 
cells (Figure 3-4). The TNF-induced stimulation of ERK1/2 affected predominantly the 
p44 isoform. However, the phosphorylation of JNK and P38 induced by TNF was 
slightly attenuated by Pellino3 knockdown. There was a very small effect on the 
phosphorylation of ERK comparing control and Pellino3 knockdown cells. Knockdown 
of Pellino3 had no effect on total levels of these kinases. These effects of Pellino3 on 
the MAPK pathway are in agreement with the previous report that Pellino 3 activated 
p38 MAPK in a TRAF6 and TAK-1 dependent manner (Butler et al., 2005). 
Given that low NF-κB activity and increased activation of MAPK signalling tends to be 
associated with pro-apoptotic effects and Pellino3 knockdown has the opposing effects 
on these pathways the present data suggest that the increased pro-apoptotic capacity of 
TNF under conditions of reduced Pellino3 are unlikely to be secondary to effects on the 
NF-κB and MAPK pathways.  
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Figure 3-3 Effects of Pellino3 knockdown on TNF-induced activation of NF-κB in Hela cells 
Hela cells were infected with lentivirus containing constructs that encoded control or human Pellino3-specific shRNA. 
Cells were grown in the presence of puromycin to select for cells showing stable integration of shRNA constructs. 
Selected cells were treated in the absence (0) or presence of human TNF (40ng/ml) for indicated times. (A) Cell 
lysates were prepared and immunoblotted for expression level of IκBα. Lysates were also probed for levels of β-actin 
to act as loading controls. (B) Nuclear extracts were prepared and subsequently incubated with an IR-labelled 
oligonucleotide containing an NF-κB-binding motif and separated by native PAGE. The arrows indicate the mobility 
of basal and TNF induced NF-κB-DNA complexes. The specificity of the NF-κB-DNA binding reaction was 
confirmed by the absence of the complexes when the binding reaction is performed in the presence of the unlabelled 
(competitor) oligonucleotide. 
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Figure 3-4 Effects of Pellino3 knockdown on TNF-induced activation of MAPKs in Hela cells. 
Hela cells were infected with lentivirus containing constructs that encoded control or human Pellino3-specific shRNA. 
Cells were grown in the presence of puromycin to select for cells showing stable integration of shRNA constructs. 
Selected cells were treated in the absence (0) or presence of human TNF (40ng/ml) for indicated times. Cell lysates 
were prepared and immunoblotted for phosphorylated levels of JNK (p-JNK), P38 (p-P38), ERK (p-ERK) and total 
levels of JNK, P38 and ERK. Lysates were also probed for levels of β-actin to act as loading controls.  
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3.3 Role of Pellino3 in TNF-induced apoptosis in various cell types 
The data above demonstrate that the suppression of Pellino3 expression hyposensitized 
Hela cells to the pro-apoptotic effects of TNF. In order to assess if such effects of 
suppressed Pellino3 expression were cell-type dependent similar studies were 
performed in three additional human cell lines (U373, 1321N1 and HEK293T). Human 
U373 MG astrocytoma cell line has been extensively used as a model system for the 
study of the activation of astrocytes by cytokines, particularly by IL-1β and TNF (Lieb 
et al., 1996; Machein et al., 1995). Human astrocytoma 1321N1 cells are widely used as 
a model system for characterizing intracellular signaling pathways and receptor-
mediated responses (Aragay et al., 1995).  HEK293T cells, a transformed cell line 
derived from human embryonic kidney preparations, are commonly used in cell biology 
research, such as a model for examining a transfected receptor, a transient expression 
host or a vehicle for the expression of recombinant proteins (Graham et al., 1977; 
Thomas and Smart, 2005).  
3.3.1 Suppression of Pellino3 expression sensitizes U373 and 1321N1 cells 
to TNF-induced apoptosis  
The human cell line U373 was initially used to evaluate if the regulatory effects of 
Pellino3 on the TNF pathway extend beyond Hela cells. In keeping with the findings 
from Hela cells, the same effects were apparent in that suppression of Pellino3 
expression in U373 lead to increased cell death (Figure 3-5), reduced cell viability 
(Figure 3-6 A) and levels of cleaved PARP, caspase-3 and caspase-8 in response to TNF 
and CHX (Figure 3-6 B). Again these pro-apoptotic effects of Pellino3 knockdown 
appear to be independent of targeting of the NF-κB and MAPK pathways since Pellino3 
knockdown in U373 cells lead to an increase in the TNF-induced degradation of IκBα 
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and a slight decrease in the phosphorylation of JNK and P38 in response to TNF (Figure 
3-7). The effect on phosphorylation of ERK was very small (Figure 3-7). These effects 
of Pellino3 knockdown on TNF signalling were also mirrored in the 1321N1 
astrocytoma in that suppressed expression of Pellino3 lead to greater cell rounding and 
detachment (Figure 3-8), reduced cell viability and increased PARP/caspase cleavage 
(Figure 3-9), prolonged degradation of IκBα and modest inhibitory effects on TNF-
induced activation of the MAPK pathways (Figure 3-10). Such uniform findings across 
the Hela, U373 and 1321N1 cell lines verify that the observed specific role of Pellino3 
knockdown in sensitizing cells to the pro-apoptotic effects of TNF is not a cell-type-
specific phenomenon and strongly supports a widespread role for Pellino3 in the TNF 
signalling pathway. 
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Figure 3-5 Knockdown of Pellino3 causes TNF-induced apoptosis in U373 cell 
U373 cells were infected with lentivirus containing constructs that encoded control or human Pellino3-specific 
shRNA. Cells were grown in the presence of puromycin to select for cells showing stable integration of shRNA 
constructs. (A) Selected cells were treated in the absence (control) or presence of human TNF (40ng/ml) plus CHX 
(10μg/ml) for 18 hr. Cells were photographed using a phase contrast microscope (bar 20μm). (B) Immunoblot 
analysis demonstrating efficacy of Pellino3 protein knockdown (with β-actin as a loading control) is also shown. 
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Figure 3-6 Knockdown of Pellino3 causes TNF-induced apoptosis in U373 cell was measured by 
MTT assay and Western blot 
U373 cells were infected with lentivirus containing constructs that encoded control or human Pellino3-specific 
shRNA. Cells were grown in the presence of puromycin to select for cells showing stable integration of shRNA 
constructs. Selected cells were treated in the absence (control) or presence of human TNF (40ng/ml) plus CHX 
(10μg/ml) for 18 hr. (A) Cells were analyzed for cell viability using MTT assays with viability expressed relative to 
control shRNA-infected cells treated with CHX alone. Data represent the mean +/- S.D. of 3 independent experiments. 
** p<0.01.   (B) Cell lysates were probed by immunoblotting for expression levels of PARP, caspase-3, caspase-8 and 
β-actin. Cleaved forms of PARP and caspase-8 are indicated by arrows.  
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Figure 3-7 Pellino3 attenuates apoptosis in U373 cells independent of NF-κB and MAPK signalling. 
U373 cells were infected with lentivirus containing constructs that encoded control or human Pellino3-specific 
shRNA. Cells were grown in the presence of puromycin to select for cells showing stable integration of shRNA 
constructs. Selected cells were treated in the absence (0) or presence of human TNF (50ng/ml) for indicated times. 
Cell lysates were prepared and immunoblotted for phosphorylated levels of JNK (p-JNK), P38 (p-P38), ERK (p-ERK) 
and total levels of IκBα, JNK, P38 and ERK. Lysates were also probed for levels of β-actin to act as loading controls. 
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Figure 3-8 Knockdown of Pellino3 causes TNF-induced apoptosis in 1321N1 cell  
1321N1 cells were infected with lentivirus containing constructs that encoded control or human Pellino3-specific 
shRNA. Cells were grown in the presence of puromycin to select for cells showing stable integration of shRNA 
constructs. Selected cells were treated in the absence (control) or presence of human TNF (40ng/ml) plus CHX 
(10μg/ml) for 18 hr. (A) Cells were photographed using a phase contrast microscope (bar 20μm). (B) Immunoblot 
analysis demonstrating efficacy of Pellino3 protein knockdown (with β-actin as a loading control) is also shown. 
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Figure 3-9 Knockdown of Pellino3 causes TNF-induced apoptosis in 1321N1 cell was measured by 
MTT assay and Western blot 
1321N1 cells were infected with lentivirus containing constructs that encoded control or human Pellino3-specific 
shRNA. Cells were grown in the presence of puromycin to select for cells showing stable integration of shRNA 
constructs. Selected cells were treated in the absence (control) or presence of human TNF (40ng/ml) plus CHX 
(10μg/ml) for 18 hr. (A) Cells were analyzed for cell viability using MTT assays with viability expressed relative to 
control shRNA-infected cells treated with CHX alone. Data represent the mean +/- S.D. of 3 independent experiments. 
***p<0.001.  (B) Cell lysates were probed by immunoblotting for expression levels of PARP, caspase-3, caspase-8 
and β-actin. Cleaved forms of PARP and caspase-8 are indicated by arrows. 
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Figure 3-10 Pellino3 attenuates apoptosis in 1321N1 cells independent of NF-κB and MAPK 
signalling. 
1321N1 cells were infected with lentivirus containing constructs that encoded control or human Pellino3-specific 
shRNA. Cells were grown in the presence of puromycin to select for cells showing stable integration of shRNA 
constructs. Selected cells were treated in the absence (0) or presence of human TNF (40ng/ml) for indicated times. 
Cell lysates were prepared and immunoblotted for phosphorylated levels of JNK (p-JNK), P38 (p-P38), ERK (p-ERK) 
and total levels of IκBα, JNK, P38 and ERK. Lysates were also probed for levels of β-actin to act as loading controls. 
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3.3.2 Knockdown of Pellino3 causes TNF-induced apoptosis in HEK293T 
cells 
To further validate the above conclusion that Pellino3 knockdown enhanced TNF-
induced apoptosis HEK293T cells was used to demonstrate that the independent 
approaches of employing shRNA expression constructs or synthesized siRNAs to 
suppress Pellino3 expression manifested the same findings in terms of increasing 
sensitivity of cells to the pro-apoptotic effects of TNF. Suppression of Pellino3 by 
shRNA increased cleavage of PARP, caspase-3 and caspase-8 after TNF plus CHX 
treatment (Figure 3-11A). After exposure with TNF plus CHX the percentage of 
apoptotic cells was approximately 30% in Pellino3 shRNA-infected cells, while in 
control shRNA-infected cells the percentage of apoptotic cells was only 22%. Upon 
treatment with CHX alone or TNF plus CHX as well as z-VAD-fmk, there was no 
observable difference in the percentages of apoptotic cells (Figure 3-11B). The shRNA 
suppression of endogenous Pellino3 expression in HEK293T was evidenced by 
immunoblot analysis (Figure 3-11C). HEK293T cells were also transfected with control 
siRNA or Pellino3-specific siRNA and stimulated with TNF (50ng/ml) for 18 hr. 
TUNEL staining experiments demonstrated a basal level of apoptosis in Pellino3 
knockdown cells with a strong increase after exposure to TNF, whilst only a few 
positive cells were observed in control cells (Figure 3-12A). The siRNA-mediated 
suppression of endogenous Pellino3 expression in HEK293T is evidenced by Western 
blot analysis (Figure 3-12B). 
As was the case with Hela, knockdown of Pellino3 delayed the resurgence of IκBα. To 
address this in more detail, cell lysates were also probed for the phosphorylation status 
of the upstream IκB kinases, IKKα and IKKβ. IKK is the major activator of NF-κB. The 
activated IKK phosphorylates IκBα, leading to IκBα ubiquitination and its degradation 
by the 26S proteasome (Karin, 1999). Cells transfected with Pellino3 siRNA showed a 
Chapter three-Results 
 
80 
stronger and more prolonged TNF-induced phosphorylation of IKKα/β Figure 3-13). 
As phosphorylation of IKK kinases is important for downstream signalling and 
activation of NF-κB, this further proves that Pellino3 acts as a negative regulator of NF-
κB.  
Phosphorylation of JNK and P38 induced by TNF in HEK293T cells were also 
attenuated by Pellino3 knockdown and there was a very small effect on phosphorylation 
of ERK comparing control and Pellino3 knockdown cells, whilst having no effects on 
total levels of these kinases (Figure 3-14). 
 
Chapter three-Results 
 
81 
 
Figure 3-11 Knockdown of Pellino3 by shRNA causes TNF-induced apoptosis in HEK293T cells 
HEK293T cells were infected with lentivirus containing constructs that encoded control or human Pellino3-specific 
shRNA. Cells were grown in the presence of puromycin to select for cells showing stable integration of shRNA 
constructs. Selected cells were treated in the absence (control) or presence of human TNF (50ng/ml), CHX (10μg/ml) 
or zVAD-fmk (20μM) for indicated times. (A) Cell lysates were probed by immunoblotting for expression levels of 
PARP, caspase-3, caspase-8 and β-actin. Cleaved forms of PARP and caspase-8 are indicated by arrows. (B) Cells 
were analyzed by flow cytometry for percentage of cells staining positive for Annexin V staining. Data represent the 
mean +/- S.D. of 3 independent experiments; **p<0.01. (C) Immunoblot analysis demonstrating efficacy of Pellino3 
protein knockdown (with β-actin as loading control) is also shown. 
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Figure 3-12 Knockdown of Pellino3 by siRNA causes TNF-induced apoptosis in HEK293T cells 
HEK293T cells were transfected with control or Pellino3-specific siRNA. Cells were treated with TNF (50ng/ml) for 
18 hr. (A) Cells were stained by TUNEL and Hoechst and subjected to confocal microscopy. Bar 20μm. (B) Cell 
lysates were probed by immunoblotting for expression levels of PARP, caspase-3, caspase-8, Pellino3 and β-actin. 
Cleaved forms of PARP and caspase-8 are indicated by arrows.  
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Figure 3-13 Effects of Pellino3 knockdown on TNF-induced activation of NF-κB in HEK293T cells.  
HEK293T cells were transfected with control or Pellino3-specific siRNA and then treated with TNF (50ng/ml) for 18 
hr. cells were treated in the absence (0) or presence of human TNF (50ng/ml) for indicated times. Cell lysates were 
prepared and immunoblotted for phosphorylated levels of IKKα/β (p-IKKα/β) and total levels of IκBα, IKKβ. Lysates 
were also probed for levels of β-actin to act as loading controls. 
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Figure 3-14 Effects of Pellino3 knockdown on TNF-induced activation of MAPKs in HEK293T 
cells. 
HEK293T cells were transfected with control or Pellino3-specific siRNA and then treated with TNF (50ng/ml) for 18 
hr. cells were treated in the absence (0) or presence of human TNF (50ng/ml) for indicated times. Cell lysates were 
prepared and immunoblotted for phosphorylated levels of JNK (p-JNK), P38 (p-P38), ERK (p-ERK) and total levels 
of JNK, P38 and ERK. Lysates were also probed for levels of β-actin to act as loading controls. 
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3.4 Pellino3 is involved in DISC formation 
Given that the proapoptotic effects of Pellino3 knockdown can not be attributed to 
inhibition of NF-κB or activation of MAPKs, the direct effects of knockdown on the 
apoptotic pathway were examined. TNF-induced apoptosis is known to proceed through 
the recruitment of proteins such as TRADD, TRAF2, RIP1, caspase-8 and FADD to 
form a complex named DISC, which together serve as a cell death checkpoint control in 
TNF-sensitive cells (Micheau and Tschopp, 2003). The role of Pellino3 in DISC 
formation was next determined. 
3.4.1 Loss of Pellino3 facilitates the formation of DISC 
The importance of Pellino3 in DISC formation was evaluated by measuring the 
interaction of DISC components, in response to TNF, in Hela cells infected with 
Pellino3 specific shRNA. Hela cells infected with Pellino3 or control shRNA were 
treated with TNF plus CHX as well as z-VAD-FMK for 2 or 5 hr. Cells were lysed and 
subjected to immunoprecipitation using an anti-caspase-8 antibody. Expression of RIP1 
and FADD in the whole cell lysates were examined by Western blotting. Co-
immunoprecipitation studies on the endogenous signalling proteins confirmed previous 
reports that TNF promotes time-dependent interaction of caspase-8 with FADD and 
RIP1 to form DISC in Hela cells (Figure 3-15) (Kundu, 2009). Upon TNF treatment, 
FADD and RIP1 formed a complex with caspase-8 at 5 hr in control cells but the levels 
of FADD and RIP1 that co-precipitated with caspase-8 were increased in Pellino3 
knockdown cells. Furthermore the interaction of caspase-8 and FADD was apparent at 
earlier times. The marked enhancement of FADD recruitment to caspase-8 was also 
confirmed in Pellino3 knockdown in HEK293T cells. The effect of knockdown of 
Pellino3 by siRNA on the recruitment of FADD to caspase-8 was examined at 2 or 5 hr 
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after stimulated with TNF plus CHX as well as z-VAD-FMK and again increased DISC 
formation was observed in Pellino3 knockdown cells (Figure 3-16). 
Collectively, these data imply that Pellino3 regulates the interaction of RIP1 and FADD 
with caspase-8 upon TNF stimulation. 
 
Figure 3-15 Knockdown Pellino3 by shRNA facilitates the formation of DISC in Hela cells. 
Hela cells were infected with lentivirus containing constructs that encoded control or human Pellino3-specific shRNA. 
Cells were grown in the presence of puromycin to select for cells showing stable integration of shRNA constructs. 
Selected cells were treated in the absence (control) or presence of human TNF (40ng/ml) plus CHX (10μg/ml) for 
indicated times. In addition to the indicated treatments all cells were treated with zVAD-fmk to prevent activation of 
caspase-8 and cell death. Cell lysates were immunoprecipitated with anti-caspase-8 antibody and immunoprecipitates 
were subsequently analyzed for co-precipitated RIP1, FADD and caspase-8 by Western blotting. The expression 
levels of RIP1, FADD, caspase-8 and Pellino3 in whole cell lysates („input‟) were also assessed by Western blotting. 
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Figure 3-16 Knockdown Pellino3 by siRNA promotes the recruitment of FADD to caspase-8 in 
HEK293T cells 
HEK293T cells were transfected with control or Pellino3-specific siRNA and then treated with human TNF 
(50ng/ml), CHX (10μg/ml) and zVAD-fmk (20mM) for indicated times. Cell lysates were immunoprecipitated with 
anti-caspase-8 antibody and immunoprecipitates were subsequently assayed for co-precipitated FADD and caspase-8 
by Western blotting. The expression levels of FADD and caspase-8 in whole cell lysates („input‟) were also assessed 
by Western blotting. 
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3.4.2 Pellino3 interacts specifically with RIP1 
RIP1 acts as a central signalling molecule in the TNF pathway by regulating the 
activation of the NF-κB and MAPKs pathways as well as the induction of apoptosis or 
necroptosis (Festjens et al., 2006; Holler et al., 2000; Kelliher et al., 1998). RIP1 
consists of a C-terminal DD, which can be recruited to several death receptors and 
interacts with FADD, a RHIM, which can be recruited to TRIF and interacts with RIP3 
( (Stanger et al., 1995; Sun et al., 2002). Ubiquitination and deubiquitination of RIP1 
play important roles in the regulation of TNF–induced NF-κB activation (Bertrand et al., 
2008; Wertz and Dixit, 2010).  
Given the importance of RIP1 in TNF signalling, coupled to the recent report of 
Pellino1 acting as an E3 ubiquitin ligase for RIP1 (Chang et al., 2009), the latter was 
examined as a potential target for Pellino3. Therefore an immunoprecipitation assay was 
performed to explore the possible interactions between Pellino3 and RIP1 after transient 
transfection in HEK293T cells. HA-tagged RIP1 was coexpressed with myc-tagged 
Pellino3s or Pellino3l, immunoprecipated with anti-myc antibodies and the subsequent 
precipitate was analyzed for the presence of HA-tagged RIP1 by anti-HA Western 
blotting. As shown in Figure 3-17A, RIP1 indeed precipitates with both Pellino3s and 
Pellino3l. The reciprocal coimmunoprecipitation assay (anti-HA immunoprecipitation 
followed by anti-myc Western blotting) also showed a positive in vivo interaction 
between Pellino3 and RIP1 (Figure 3-17B). 
To investigate whether or not Pellino3 directly binds to RIP1, an in vitro binding assay 
was performed. Purified recombinant forms of Pellino3s and 3l were shown to be each 
capable of pulling down in vitro translated RIP1 from lysates of HEK293T cells (Figure 
3-17C). RIP1 does not bind to the beads alone.  
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Figure 3-17 : Pellino3 interacts with RIP1. 
(A, B) HEK293T cells were co-transfected with indicated combinations of constructs encoding HA-tagged RIP1 and 
myc-tagged Pellino3s or Pellino3l. The caspase inhibitor CrmA was also trasfected to prevent caspase induced 
cleavage of RIP1 and consequently cell apoptosis . (A) Cell lysates were immunoprecipitated (IP) using anti-myc 
antibody, followed by immunoblotting using anti-HA for RIP1. (B) Reciprocal coimmunoprecipitation assays were 
performed using anti-HA antibody followed by immunoblotting using anti-myc antibody for Pellino3. RIP1, Pellino3 
and the precipitated IgG heavy chain (IgGH) are indicated by arrows. (C) Purified myc-tagged Pellino3s, Pellino3l, 
was immunoprecipitated with anti-myc antibody and then incubated with HEK293T cell lysates from cells previously 
transfected with HA-tagged RIP1. Samples were then precipitated (myc-pulldown) and analysed by immunoblotting 
using anti-myc and -HA antibodies. Input HA-RIP1 protein is shown at right. 
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3.4.3 Pellino3 interacts directly with the caspase domain of caspase-8  
Pellino3 was next assessed for its ability to interact with another component of the 
DISC, caspase-8. The co-expression of HA-tagged pro-caspase-8 (with a mutation to 
prevent autocleavage) with myc-tagged Pellino3s or Pellino3l followed by co-
immunoprecipitation analysis demonstrated that Pellino3 proteins and pro-caspase-8 
were reciprocally co-immunoprecipitated (Figure 3-18).  
The interaction between Pellino3 and procaspase-8 is direct in nature since purified 
recombinant forms of both proteins interact with each other in vitro (Figure 3-19).  
To map the interaction regions between procaspase-8 and Pellino3 proteins the 
interaction of Pellino3 with various caspase-8 mutants was evaluated. Procaspase-8 
contains two death effector domains (DEDa and DEDb) in its N-terminal pro-domain 
(residues 1-194) and a C-terminal region (residues 195-479) that encodes  the catalytic 
large (p18) and small subunits (p10) (Fan et al., 2005). The DED is a protein interaction 
domain that plays a critical role for caspase-8 dimerization and for its interaction with 
FADD. Schematic illustration of Procaspase-8 and its truncated constructs is shown on 
Figure 3-20A. Expression constructs encoding procaspase-8, DEDa / DEDb and caspase 
regions of caspase-8 were co-expressed with Pellino3s in HEK293T cells. Procaspase-8 
and its caspase region were shown to interact with Pellino3 using co-
immunoprecipitation analysis whereas there was no such interaction between the 
DEDa/DEDb domain and Pellino3 (Figure 3-20B). The interaction of the caspase 
domain with Pellino3 was proven to be direct in nature by showing that purified 
recombinant forms of the caspase domain interacts with Pellino3 in vitro (Figure 3-21), 
whereas the DED domain fails to interact with Pellino3 (Figure 3-22).       
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Figure 3-18 Pellino3 co-immunoprecipitates with caspase-8. 
HEK293T cells were co-transfected with indicated combinations of constructs encoding HA-tagged procaspase-8 and 
myc-tagged Pellino3s or Pellino3l. (A) Cell lysates were immunoprecipitated (IP) using anti-myc antibody, followed 
by immunoblotting using anti-HA for procaspase-8. (B) Reciprocal coimmunoprecipitation assays were performed 
using anti-HA antibody followed by immunoblotting using anti-myc antibody for Pellino3.  
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Figure 3-19 Pellino3 interacts directly with caspase-8. 
Purified myc-tagged Pellino3s or Pellino3l was immunoprecipitated with anti-myc antibody and then incubated with 
purified procaspase-8 protein. Samples were then precipitated (myc-pulldown) and analysed by immunoblotting 
using anti-myc or –caspase-8 antibodies. Input procaspase-8 protein is shown at right. 
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Figure 3-20 Pellino3 interacts with caspase-8 via its caspase domain in HEK293T cells.  
(A) Procaspase-8 and its truncated constructs, caspase-8 DED domain (residues 1-194), caspase-8-caspase domain 
(residues 195-479) were chematic illustrated. (B) HEK293T cells were co-transfected with the indicated 
combinations of constructs encoding myc-tagged procaspase-8, caspase-8 DED domain, caspase-8-caspase domain 
and flag-tagged Pellino3s. Cell lysates were immunoprecipitated (IP) using an anti-flag antibody, followed by 
immunoblotting using anti-myc, -flag or –β-actin antibodies. 
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Figure 3-21 Pellino3 interacts directly with caspase-8 via its caspase domain.  
Purified myc-tagged Pellino3s or Pellino3l was immunoprecipitated with anti-myc antibody and then incubated with 
purified caspase-8 caspase domain. Samples were then precipitated (myc-pulldown) and analysed by immunoblotting 
using anti-myc or –caspase-8 antibodies. Samples of recombinant Pellino proteins and caspase-8 caspase domain, 
prior to immunoprecipitation (Input), were similarly analysed by immunoblotting. The mobility of each protein, 
including the precipitated IgG heavy chain (IgGH), is indicated by an arrow. 
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Figure 3-22 Pellino3 does not interacts with caspase-8 DED domain in vitro. 
Purified myc-tagged Pellino3s or Pellino3l was immunoprecipitated with anti-myc antibody and then incubated with 
purified caspase-8 DED domain. Samples were then precipitated (myc-pulldown) and analysed by immunoblotting 
using anti-His-HRP antibody. 
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recruitment of subsequent caspases and thereby activating a cysteine protease cascade 
leading to cell death (Muzio et al., 1996). 
Expression constructs encoding Flag-FADD were co-expressed with Pellino3s in 
HEK293T cells. Co-immunoprecipitation analysis showed that there was no interaction 
between FADD and Pellino3 (Figure 3-23). 
 
Figure 3-23 Pellino3 does not interact with FADD.  
HEK293T cells were co-transfected with indicated combinations of constructs encoding Flag-tagged FADD and myc-
tagged Pellino3s. Cell lysates were immunoprecipitated (IP) using anti-myc antibody, followed by 
immunoblotting using anti-Flag for FADD. 
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3.5 The FHA domain of Pellino3 mediates its capacity for regulating 
DISC formation  
Pellino proteins contain an N-terminal cryptic phospho-threonine-binding FHA domain 
that facilitates interaction with phosphorylated IRAK1 (Lin et al., 2008) and a C-
terminal RING-like domain that catalyses K63 polyubiquitination of IRAKs (Butler et 
al., 2007; Ordureau et al., 2008; Schauvliege et al., 2006).  
The functional contributions of the different domains of Pellino3 to its regulatory 
effects on TNF signalling were next assessed. This was addressed by experiments that 
aimed to rescue the phenotypic effects of Pellino3 knockdown on TNF signalling in 
HEK293T cells, using various forms of Pellino3. A series of mutants were generated: 
firstly, FHA domain mutants in which arginine (R) and serine (S) were mutated to 
alanine (A) at residues 155 and 185 in Pellino3l and residues 131 and 161 in Pellino3s, 
respectively (Figure 3-24A), and secondly RING domain mutants in which the cysteine 
(C) residues 384 and 387 in Pellino3l and residues 360 and 363 in Pellino3s were 
mutated to alanine (A), respectively (Figure 3-24B).  
Wild-type or mutant forms of myc tagged Pellino3 were introduced into Pellino3 
shRNA-infected HEK293T cells. TNF-induced apoptosis was tested by FACS and 
Western blotting. These experiments revealed that wild-type Pellino3 protected Pellino3 
deficient cells from TNF-induced apoptosis, indicating that both spliced forms can 
temper the pro-apoptotic signalling of TNF. Intriguingly forms of Pellino3, containing 
mutations in their RING-like domain inhibited the ability of TNF to promote increased 
Annexin V staining and cleavage of PARP and caspase-3 in Pellino3 knockdown cells. 
By contrast, FHA domain mutants of Pellino3 (Pellino3 FHAm) failed to mimic their 
wild type counterparts in rescuing the pro-apoptotic effects of TNF (Figure 3-25). At 24 
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hr post-transfection, cells were treated with TNF plus CHX for another 5 hr before cell 
viability analysis. As shown in Figure 3-25A, overexpression of wild-type and RING 
domain mutants of Pellino3 enhanced cell viability compared with control cells (EV: 
37%). In contrast, Pellino3-FHA mutants failed to inhibit the TNF-induced increases in 
Annexin V staining. Western blot analysis further showed that the expression of 
Pellino3 FHA mutants failed to rescue the increase cleavage of PARP and caspase-3 
that was observed in response to Pellino3 knockdown (Figure 3-25B). In contrast, wild-
type Pellino3 and RING domain mutants of Pellino3 successfully reduced caspase-3 and 
PARP cleavage. These data suggest a dispensable role for the RING-like domain of 
Pellino3 in manifesting its regulatory effects on TNF signalling. In contrast the FHA 
domain is of crucial importance. 
To determine whether Pellino3‟s FHA domain mediates Pellino3‟s capacity to regulate 
DISC formation and whether it regulates the association of DISC proteins, wild-type or 
mutant forms of myc-tagged Pellino3 were introduced into Pellino3 shRNA infected 
HEK293T cells. Cells were treated with TNF plus CHX for 5 hr with the presence of 
zVAD-fmk to prevent activation of caspase-8 and cell death. The associated proteins in 
the lysates were pulled down with anti-caspase-8 antibody. The expression of RIP1 and 
FADD in immunoprecipitates and cell lysates were analyzed by Western blotting. Wild-
type Pellino3s blocked the recruitment of endogenous FADD to caspase-8 and 
attenuated the interaction between RIP1 and caspase-8. The E3 mutant showed very 
similar ability like its wild type counterpart. However, introduction of the FHA mutant 
Pellino3s did not affect the interaction between FADD and caspase-8 or RIP1 and 
caspase-8 (Figure 3-26). This rescue experiment was also performed with Pellino3l and 
its mutants and equivalent results were apparent (Figure 3-27), suggesting both forms of 
Pellino3 can control TNF-induced apoptosis by regulating the formation of DISC. 
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These findings also indicate a critical role for the FHA domain of Pellino3 proteins in 
counter-regulating the pro-apoptotic proclivity of TNF signalling.  
 
 
Figure 3-24 Mutational analysis of Pellino3. 
(A) Partial nucleotide sequence of Pellino3 from the wild-type (upper panel) and FHA mutated (lower panel) alleles. 
The mutations are indicated by an arrow. (B) Partial nucleotide sequence of Pellino3 from the wild-type (upper panel) 
and RING mutated (lower panel) alleles. The mutations are indicated by an arrow. 
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Figure 3-25 Wild type and RING mutants of Pellino3 rescue cells from TNF-induced apoptosis but 
FHA mutants are ineffective. 
HEK293T cells, previously transfected with an expression construct encoding Pellino3-specific shRNA, were 
transfected with pcDNA3.1 empty vector (EV) or pcDNA3.1 encoding myc-tagged Pellino3s, Pellino3l, 
Pellino3sFHAm, Pellino3lFHAm, Pellino3sE3m or Pellino3lE3m. Transfected cells were treated with human TNF 
(40ng/ml) and CHX (10 μg/ml) for 5 hr. (A) Cells were analyzed by flow cytometry for percentage of cells staining 
positive for Annexin V staining. Data represent the mean +/- S.D. of 3 independent experiments; ***p<0.001. (B) 
The expression levels of Pellino3, PARP, cleaved caspase-3 and β-actin were measured in cell lysates by Western 
blotting. 
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Figure 3-26 Wild type and RING mutants of Pellino3s inhibit TNF-induced formation of DISC.  
HEK293T cells, previously transfected with an expression construct encoding Pellino3-specific shRNA, were 
transfected with pcDNA3.1 empty vector (EV) or pcDNA3.1 encoding myc-tagged Pellino3s, Pellino3sFHAm or 
Pellino3sE3m. In addition to the indicated treatments with TNF and CHX (above) cells were also treated with zVAD-
fmk to prevent activation of caspase-8 and cell death. Cell lysates were immunoprecipitated with an anti-caspase-8 
antibody and immunoprecipitates were subsequently analyzed for co-precipitated RIP1, FADD and caspase-8 by 
Western blotting. The expression levels of RIP1, FADD, caspase-8, Pellino3 and β-actin were measured in whole cell 
lysates („input‟) by Western blotting. 
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Figure 3-27 Wild type and RING mutants of Pellino3l inhibit TNF-induced formation of DISC. 
HEK293T cells, previously transfected with an expression construct encoding Pellino3-specific shRNA, were 
transfected with pcDNA3.1 empty vector (EV) or pcDNA3.1 encoding myc-tagged Pellino3l, Pellino3lFHAm or 
Pellino3lE3m. In addition to the indicated treatments with TNF and CHX (above) cells were also treated with zVAD-
fmk to prevent activation of caspase-8 and cell death. Cell lysates were immunoprecipitated with an anti-caspase-8 
antibody and immunoprecipitates were subsequently analyzed for co-precipitated RIP1, FADD and caspase-8 by 
Western blotting. The expression levels of RIP1, FADD, caspase-8, Pellino3 and β-actin were measured in whole cell 
lysates („input‟) by Western blotting. 
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Given the ability of Pellino3 to regulate TNF-induced DISC formation, the dynamics of 
interactions between Pellino3 and the components of DISC were assessed in response to 
TNF. 
Co-immunopreciptiation analyses demonstrated that TNF promoted a strong and time-
dependent interaction between endogenous RIP1 and Pellino3s (Figure 3-28 left panels) 
or Pellino3l (Figure 3-28 right panels). The recruitment of RIP1 to wild type Pellino3 
was detectable following TNF stimulation within 2 hr. In contrast, TNF fails to drive 
the interaction of RIP1 with mutants of Pellino3 that lack a fully functional FHA 
domain (Figure 3-29). However the introduction of mutations in the RING-like domain 
of Pellino3s and Pellino3l failed to affect their associations with RIP1 or caspase-8 
(Figure 3-30) excluding a role for this domain in facilitating such interactions. This is 
consistent with the lack of importance of the RING-like domain in mediating the 
regulatory effects of Pellino3 on TNF signalling.  
Interestingly both spliced forms of Pellino3 interacted with endogenous caspase-8 in 
unstimulated cells and treatment with TNF failed to further enhance this interaction 
(Figure 3-28). Furthermore neither form of Pellino3 showed association with FADD 
irrespective of the absence or presence of TNF (third panel of Figure 3-28) and this is 
consistent with co-immunoprecipitation analysis with overexpressed proteins (Figure 3-
23). The FHA mutants showed constitutive binding to caspase-8 (second panel of 
Figure 3-29) suggesting that the FHA domain is important for RIP1 binding but 
dispensable for caspase-8 binding.  
These findings suggest a critical role for the FHA domain in facilitating the regulatory 
effects of Pellino3 on TNF signalling by targeting of RIP1 in response to TNF 
stimulation. 
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Figure 3-28 Pellino3 recruits RIP1 in response to TNF. 
HEK293T cells were transfected with an empty vector (EV) or expression constructs encoding myc-taggged 
Pellino3s or Pellino3l. Cells were then treated in the absence or presence of TNF (50ng/ml) and CHX (10μg/ml) for 
indicated times. Cells were also treated with the pan-caspase inhibitor: zVAD-fmk (20μM) to prevent full activation 
of caspase-8 and cell death. Cell lysates were immunoprecipitated with an anti-myc antibody and immunoprecipitates 
were subsequently co-precipitated RIP1, caspase-8, FADD and myc-tagged Pellino proteins by Western blotting. The 
precipitated IgG light chain (IgGL) is indicated by an arrow. The expression levels of RIP1, caspase-8, FADD and 
myc-tagged Pellino proteins were measured in whole cell lysates („input‟) by Western blotting. 
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Figure 3-29 The FHA domain of Pellino3 is important for mediating its interaction with RIP1 in response 
to TNF.  
HEK293T cells were transfected with an empty vector (EV) or expression constructs encoding FHA domain mutant 
forms of Pellino3s (P3sFHAm) or Pellino3l (P3lFHAm). Cells were then treated in the absence or presence of TNF 
(50ng/ml) and CHX (10μg/ml) for indicated times. Cells were also treated with the pan-caspase inhibitor: zVAD-fmk 
(20μM) to prevent full activation of caspase-8 and cell death. Cell lysates were immunoprecipitated with an anti-myc 
antibody and immunoprecipitates were subsequently co-precipitated RIP1, caspase-8, FADD and myc-tagged Pellino 
proteins by Western blotting. The precipitated IgG light chain (IgGL) is indicated by an arrow. The expression levels 
of RIP1, caspase-8, FADD and myc-tagged Pellino proteins were measured in whole cell lysates („input‟) by Western 
blotting. 
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Figure 3-30 The RING-like domain of Pellino3 is dispensable for mediating its interaction with RIP1 in 
response to TNF. 
HEK293T cells were transfected with an empty vector (EV) or expression constructs encoding RING-like domain 
mutant forms of Pellino3s (P3sE3m) or Pellino3l (P3lE3m). Cells were then treated in the absence or presence of 
TNF (50ng/ml) and CHX (10μg/ml) for indicated times. Cells were also treated with the pan-caspase inhibitor: 
zVAD-fmk (20μM) to prevent full activation of caspase-8 and cell death. Cell lysates were immunoprecipitated with 
an anti-myc antibody and immunoprecipitates were subsequently co-precipitated RIP1, caspase-8, FADD and myc-
tagged Pellino proteins by Western blotting. The precipitated IgG light chain (IgGL) is indicated by an arrow. The 
expression levels of RIP1, caspase-8, FADD and myc-tagged Pellino proteins were measured in whole cell lysates 
(„input‟) by Western blotting. 
 
 
(KDa)
RIP1
Caspase8
Caspase 8
RIP1
In
p
u
t
TNFα + CHX  :         0       2      5    5hr 0      2      5     5hr
EVP3sE3m P3lE3m
Z-VAD-FMK :      +      +     +    +         +    +     +     +
IP :      Myc
EV
Myc
Myc
72
95
Chapter three-Results 
 
107 
Since the targeting of RIP1 by Pellino3 may act as a key contributing mechanism to the 
regulatory effects of the latter on the TNF pathway, the Pellino3-RIP1 interaction was 
further characterized. The FHA mutants of both Pellino3 proteins were compared with 
their wild type counterparts in terms of their capacity to interact with RIP1 using co-
immunoprecipitation assay (Figure 3-31). The result demonstrates that the co-
expression of either Pellino3s or Pellino3l with RIP1 leads to strong Pellino3-RIP1 
interaction but point mutations in the FHA domains of both forms of Pellino3 leads to 
dramatic decreases in the levels of this Pellino3-RIP1 interaction, supporting a model 
where the FHA domain of Pellino3 facilitates its direct interaction with RIP1. 
The reduced interaction is also evident in direct binding assays in vitro in which 
purified recombinant forms of the FHA mutants of Pellino3 failed to match their wild 
type counterparts in pulling down RIP1 from cell lysates (Figure 3-32). These findings 
support a model where Pellino3, via its FHA domain, directly targets RIP1 and so 
regulates DISC formation and ultimately apoptosis in response to TNF. 
 
Figure 3-31 FHA domain of Pellino3 is required for its in vivo interaction with RIP1.   
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HEK293T cells were co-transfected with indicated combinations of constructs encoding HA-tagged RIP1 and myc-
tagged Pellino3s or Pellino3l or their corresponding FHA mutants as described above. Such transfections also 
included co-expression of the caspase inhibitor CrmA to prevent caspase induced cleavage of RIP1 and cell apoptosis. 
Cell lysates were immunoprecipitated (IP) using an anti-myc antibody followed by immunoblotting using anti-HA or 
-myc antibodies. Cell lysates, prior to immunoprecipitation (Input), were similarly analysed by immunoblotting. 
 
Figure 3-32 FHA domain of Pellino3 is required for its direct interaction with RIP1 in vitro.   
Purified myc-tagged Pellino3s, Pellino3l or their FHA mutant counterparts were immunoprecipitated with an anti-
myc antibody and then incubated with HEK293T cell lysates from cells previously transfected with HA-tagged RIP1. 
Samples were then precipitated (myc-pulldown) and analysed by immunoblotting using anti-HA or -myc antibodies. 
A cell lysate (prior to immunopreciptation (input)) from HEK293T cells previously transfected with HA-tagged RIP1 
was also subjected to similar Western blot analysis. 
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3.6 Studies on Pellino3 knockout mice 
3.6.1 Generation and genotyping Pellino3 knockout mice 
In order to define the physiological relevance of the above findings and the role of 
Pellino3 in TNF signalling, Pellino3-deficient mice were generated with a floxed 
Pellino3 allele according to the strategy outlined in Figure 3-33. A mouse strain in 
which the Pellino3 gene was flanked by loxP sites was generated by Taconic Artemis 
using its proprietary technology. Briefly a targeting vector was constructed in which 
exon3 of the Pellino3 gene was flanked by loxP sites and the positive selection marker 
(Puro) was inserted into intron 2. The targeting vector was generated using BAC clones 
from the C57BL/6J RPCI-23 BAC library and transfected into the Taconic Artemis 
C57BL/6N Tac ES cell line. Homologous recombinant clones were isolated using 
positive (Puromycin resistance) and negative (Thymidine kinase - Tk) selections and 
these were used for the generation of chimeric mice by blastocyst injection. Highly 
chimeric males were mated with C57BL/6 females and heterozygous offspring were 
identified by Southern blotting. To generate constitutive Pellino3-deficient mice, mice 
that were heterozygous for the targeted allele were bred with mice containing Cre 
recombinase regulated by the ROSA26 locus (C57BL/6-Gt(ROSA)26Sor
tm
16
(Hasan et 
al.)Arte
). This results in the deletion of exon 3 and loss of function of the Pellino3 gene by 
generating a frameshift in all downstream exons. The Cre transgene was subsequently 
removed by breeding the resulting Pellino3
+/-
 mice with C57BL/6 mice during colony 
expansion. Mice were genotyped by PCR analysis of DNA isolated from ear punches. 
Genotyping was performed using the PCR strategies described in chapter 2.2.1.4. An 
example of a typical gel picture of Pellino3 genotyping PCR is given in Figure 3-34. 
Genotyping PCR was performed to detect heterozygous/homozygous conventional 
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alleles (Figure 3-34 upper).  A large internal control (585 bp) was amplified in each 
reaction. Genotypes that are homozygous or heterozygous support amplification as 
detected by the presence of a 370 bp band, whereas genotypes that are wild type do not 
support amplification. Genotyping PCR was also to detect heterozygous/homozygous 
conditional and wild type alleles (Figure 3-34 lower). Genotypes that are wild type or 
heterozygous support amplification as detected by presence of a 210 bp band, whereas 
genotypes that are homozygous fail to show an amplified fragment. 
Confirmation of gene disruption was performed by RT–PCR and Real-time PCR. 
Primers that are specific to exon 3 of the murine Pellino3 gene were used to amplify 
Pellino3 mRNA, isolated from MEFs, in semi-quantitative ( 
Figure 3-35A) and real time RT-PCR ( 
Figure 3-35B). These studies demonstrated that Pellino3 mRNA expression was absent 
in Pellino3
-/-
 mice.   
To determine the effect of the Pellino3 knockout on expression of Pellino3 protein, Cell 
lysates were prepared from both WT and homozygous Pellino3 MEFs and subjected to 
Western blotting. Probing with an polyclonal anti-Pellino3 antibody revealed a Pellino3 
protein of about 50 kDa in MEFs from wild-type embryo and this is absent in MEFs 
from Pellino3-deficient embryo  (Figure 3-36). 
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Figure 3-33 Generation of Pellino3 knockout mice. 
Diagram shows:the mouse Pellino3 gene; the Pellino3 targeting vector containing exon3 flanked by loxP sites, the postive selection marker (Puro) inserted into intron 2 and a downstream 
Thymidine Kinase (TK) gene; the targeted Pellino3 allele; and the Pellino3 knockout allele after Cre recombination. Homologous recombinants in ES cells were isolated by Puro selection and 
used for blastocyst injection. Mice that were heterozygous for the targeted allele were bred with mice containing Cre recombinase regulated by the ROSA26 locus thus generating constitutive 
Pellino3-deficient mice in which deletion of exon 3 results in loss of function of the Pellino3 gene by generating a frameshift in all downstream exons. Exons are numbered and regions targeted 
by genotyping primers are also indicated.   
Chapter three-Results 
 
112 
 
 
Figure 3-34 Identification of genotypes by PCR. 
Genotyping was performed by PCR on genomic DNA from ear punches. Primers a and b differentiate the wild type 
allele (Pellino3+/+) from the Pellino3 knockout allele in heterozygous (Pellino3+/-) and homozygous (Pellino3-/-) 
mice based on different fragment size where primers c and d amplify a fragment from the WT allele but not the 
knockout allele. Water was used as negative control for the PCR reaction. 
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Figure 3-35 Expression level of Pellino3 mRNA in Pellino3 knockout mice. 
MEFs were isolated from Pellino3+/+ and Pellino3-/- embryos. (A) cDNA was prepared and semi-quantitative RT-
PCR was used with specific primers to amplify exon 3 of Pellino3 or a region of the housekeeping gene HPRT. (B) 
Real time RT-PCR was used to quantify the levels of Pellino3 mRNA expression. 
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Figure 3-36 Expression level of Pellino3 Protein in Pellino3 knockout mice. 
MEFs were isolated from Pellino3+/+ and Pellino3-/- embryos. Cell lysates were prepared and subjected to Western 
blotting using anti-Pellino3 or anti-β-actin antibodies. 
3.6.2 Phenotype of Pellino3-deficient mice 
Both heterozygous and homozygous Pellino3-deficient mice were viable. Mating of 
heterozygous animals fed on standard mouse chow produced offspring with the 
1:1.48:0.7 proportions of wild-type: heterozygous: homozygous mutant (n = 88:120:62) 
at 21 days of age (Figure 3-37A). When two heterozygous mice are bred together, 25% 
of pups derived from these matings should be homozygous. This is the expected 
Mendelian ratio, which is followed by most knockout mouse descriptions, such as 
XIAP-deficient mice (Harlin et al., 2001). However, genetic ablation of some genes 
alters the embryo survival capacity, thus resulting in the birth of fewer homozygous 
mutant mice than expected (or none), such as caspase-8-deficient mice (Sakamaki et al., 
2002). The proportions for heterozygous: homozygous mutant offspring of Pellino3 
P3+/+ P3 -/-
Actin 
Pellino3
50kd
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were lower than the expected Mendelian ratios, suggesting that there could be fetal loss 
of heterozygous and homozygous mutant Pellino3 mice during gestation. 
The heterozygous and homozygous mice grew normally and appeared healthy. Body 
weights of offspring were measured at 7 (male) or 8 (female) weeks of age. There was 
no significant difference in body weight between wild-type and heterozygous mice, 
whereas body weights of homozygous knockout mice were both significantly less than 
those of wild-type and heterozygous animals (Figure 3-37B and C).  
 
Figure 3-37 Phenotype of Pellino3 knockout mice. 
(A) Numbers and percentages of pups of the indicated genotypes obtained from Pellino3 heterozygote intercrosses. 
(B,C) Weights of 7 week-old male mice (B) and 8 week-old female mice (C) from the breeding of Pellino3+/- mice. 
Horizontal bars indicate mean weights for each genotype. ***p<0.001, **p<0.01,*p<0.05, n=14. 
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3.6.3 Cells from Pellino3-deficient mice show increased sensitivity to the 
pro-apoptotic effects of TNF.  
MEFs from Pellino3
+/+
 and Pellino3
-/-
 mice were thus used to assess the effects of 
Pellino3 deficiency on TNF signalling. WT and homogenous MEF cells were 
stimulated with TNF (40ng/ml) plus CHX (10μg/ml) for 10 hr. Co-stimulation of these 
cells with TNF and CHX caused the cells to become rounded and non-adherent but 
such phenotypic changes were much more apparent in MEFs from Pellino3
-/-
 embryos 
relative to their wildtype control cells (Figure 3-38A). As measured by Annexin V, 
TNF plus CHX killed approximately 40% of Pellino3 deficient cells, compared to only 
24% of control cells (Figure 3-38B), whilst there was no difference when cells were 
treated with CHX alone. Absence of Pellino3 also caused increased cleavage of PARP, 
caspase-3 after TNF plus CHX treatment (Figure 3-38C).  
To further confirm the regulatory effects of Pellino3 on the TNF signalling pathway, 
rescue experiments were performed in Pellino3
−/−
 MEFs using retroviruses. An 
MSCV-based construct containing the Pellino3 coding sequence was generated by 
PCR. This construct contained the entire coding sequence of Pellino3, followed by an 
internal ribosomal entry sequence (IRES) to allow for GFP expression. Pellino3
−/−
 
MEFs were infected with MSCV, lacking (retrovirus) or containing the myc-tagged 
murine Pellino3 gene and then apoptosis was induced by treatment of TNF and CHX. 
Control cells were transfected with the empty vector (retrovirus), and high cell death 
was observed. In contrast, expression of Pellino3 successfully rescued Pellino3
−/− 
MEFs from TNF-induced apoptosis (Figure 3-39A). Total percent of apoptotic cells 
decreased from 45% in the control cells to 25% with Pellino3 expression, as measured 
by Annexin V-FITC staining (Figure 3-39B). Expression of Pellino3 also attenuated the 
cleavage of caspase-3 and PARP in Pellino3-deficient MEFs (Figure 3-39C). These 
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results clearly demonstrate that Pellino3 acts as an anti-apoptotic factor in TNF-
induced apoptosis. 
Similar to the results from cell lines, knockout of Pellino3 delayed the resurgence of 
IκBα and increased levels of phosphorylation IκBα (Figure 3-40A). Activation of NF-
κB in Pellino3 deficient MEFs was confirmed using EMSA. Interestingly, even 
Pellino3 heterozygous MEFs induced activation of NF-κB after TNF treatment (Figure 
3-40B). Knockout of Pellino3 also attenuated activation of JNK and P38, and to some 
extent increased activation of ERK (Figure 3-41). The stimulatory effects of Pellino3 
deficiency on NF-κB was further confirmed by increased TNF-induced expression of 
the NF-κB-responsive gene IL-6 in Pellino3-/- MEFs (Figure 3-42) and thus Pellino3 
may also regulate inflammatory signalling.  
To further evaluate the effect of Pellino3 deficiency in TNF signalling, basal and TNF-
induced expression levels of several antiapoptotic proteins mediated by NF-κB or 
MAPKs, such as A20, c-FLIP and Bcl-x, were examined on mRNA level or protein 
level. Treatment of MEFs with TNF for 5 hours, resulted in induction of A20 mRNA, 
as determined by quantitative real-time PCR analysis. TNF-induced A20 mRNA levels 
were significantly increased in Pellino3
-/-
 MEFs (Figure 3-43A), suggesting that 
Pellino3 attenuates A20 transcription. Since A20 has been described to terminate TLR-
mediated NF-κB up-regulation (Wertz et al., 2004), the inhibition of A20 by Pellino3 
may alter the duration and the extent of the NF-κB activity. cFLIP has the ability to 
form heterodimers with procaspase-8 and inhibit its full activation, preventing 
apoptosis (Krueger et al., 2001; Geserick et al., 2008). Transcription of c-FLIP in 
response to TNF stimulation was slightly up regulated in Pellino3
-/-
 MEFs (Figure 3-
43B). Bcl-x has the ability to bind to pro-apoptotic proteins and is associated with 
apoptosis resistance (Jourdan et al., 2000; Boise et al., 1993). The protein levels of 
Bcl-x remained unchanged during TNF treatment in Pellino3
-/-
 MEFs (Figure 3-43C). 
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These findings, in support of the data obtained from cell lines, provide strong evidence 
that Pellino3 play a key role in regulating apoptosis in response to TNF. Furthemore 
the underlying mechanism appears to be independent of regulatory effects on NF-κB or 
the expression of anti-apoptotic proteins.  
 
Figure 3-38 Genetic Knockout of Pellino3 promotes TNF-induced apoptosis in MEFs 
MEFs were isolated from Pellino3+/+ and Pellino3-/- embryos and treated in the absence (control) or presence of 
murine TNF (20ng/ml) plus CHX (10μg/ml) for 10 hr. (A) Cells were photographed using a phase contrast 
microscope (bar 20μm). (B) Cells were analyzed by flow cytometry for percentage of cells staining positive for 
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Annexin V. Data represent the mean +/- S.D. of 3 independent experiments. (C) Cell lysates were probed by 
immunoblotting for expression levels of PARP, caspase-3 and β-actin. 
 
 
Figure 3-39 Pellino3 rescues Pellino3
−/− 
MEFs from TNF-induced apoptosis. 
MEFs, from Pellino3-/- embryos, were retrovirally infected with MSCV, lacking (retrovirus) or containing the myc-
tagged murine Pellino3 gene (mPellino3 retrovirus). Infected cells were treated in the absence (control) or presence 
of human TNF (40ng/ml) and CHX (10μg/ml) for 10 hr. (A) Cells were photographed using a phase contrast 
microscope (bar 20μm) or (B) viewed by fluorescent microscopy to detect infected cells based on expression of 
MSCV-encoded GFP. The mean +/- S.D. of 3 independent experiments; **p<0.01. or (C) Cell lysates were probed 
by immunoblotting for expression levels of PARP, caspase-3, myc, β-actin and GFP. 
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Figure 3-40 Loss of Pellino3 enhances TNF-induced activation of NF-κB in MEFs. 
(A) MEFs were isolated from Pellino3+/+ and Pellino3-/- embryos and treated in the absence (0) or presence of 
murine TNF (20ng/ml) for indicated times. Cell lysates were prepared and immunoblotted for phosphorylated levels 
of IκBα (p-IκBα) and total levels of IκBα. Lysates were also probed for levels of β-actin to act as loading controls. 
(B) MEFs were isolated from Pellino3+/+, Peli3+/– and Pellino3-/- embryos and treated in the absence (0) or presence 
of murine TNF (50ng/ml) for indicated times. Nuclear extracts were prepared and subsequently incubated with an 
IR-labelled oligonucleotide containing an NF-κB-binding motif and separated by native PAGE. The arrows indicate 
the mobility of basal and TNF induced NF-κB-DNA complexes. The specificity of the NF-κB-DNA binding 
reaction was confirmed by the absence of the complexes when the binding reaction is performed in the presence of 
the unlabelled (competitor) oligonucleotide. 
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Figure 3-41  Effects of Pellino3 knockout on TNF-induced activation of MAPKs in MEFs 
MEFs were isolated from Pellino3+/+ and Pellino3-/- embryos and treated in the absence (0) or presence of murine 
TNF (20ng/ml) for indicated times. Cell lysates were prepared and immunoblotted for phosphorylated levels of JNK 
(p-JNK), P38 (p-P38), ERK (p-ERK) and total levels of JNK, P38 and ERK. Lysates were also probed for levels of 
β-actin to act as loading controls. 
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Figure 3-42 Effects of Pellino3 deficiency on TNF-induced expression of IL-6. 
MEFs were isolated from Pellino3+/+ and Pellino3-/- embryos and treated in the absence (control) or presence of 
murine TNF (20ng/ml) for the indicated time periods. Conditioned media from treated cells were assayed for levels 
of IL-6 by ELISA. Data represent the mean +/- S.D. of 3 independent experiments; *** P < 0.001. 
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Figure 3-43 Effects of Pellino3 deficiency on expression of anti-apoptotic proteins in response to 
TNF. 
MEFs were isolated from Pellino3+/+ and Pellino3-/- embryos and treated in the absence (control) or presence of 
murine TNF (20ng/ml) for the indicated time periods. (A,B) mRNA expression levels of A20 (A) and cFLIP (B) 
were measured by quantitative RT-PCR and expressed relative to expression levels in unstimulated Pellino3+/+ 
MEFs. Data represent the mean +/- S.D. of 3 independent experiments; **p<0.01. (C) Cell lysates were probed by 
immunoblotting for expression levels of Bcl-x and β-actin. 
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3.6.4 Pellino3 confers protection against hepatoxicity and lethality in 
response to in vivo administration of TNF. 
In order to define the in vivo role of Pellino3 in the context of the cytotoxic effects of 
TNF the well established liver injury model was employed in which the hepatotoxic 
agent D-gal sensitizes mice to the lethal effects of low doses of TNF. In this model 
mice die due to acute hepatitis, which is characterized by leukocyte influx, apoptosis, 
and secondary necrosis (Decker and Keppler, 1974). Mice usually start dying after 6 or 
8 hr after injection with a combination of TNF (10µg/kg body weight) and D-Gal 
(0.8g/kg body weight) (Nagaki et al., 1999 ; Van Molle et al., 1997).  
In this study, Pellino3 homozygous mice and their wild type counterparts were injected 
intraperitoneally with a combination of D-Gal (0.8g/kg body weight) and low dose of 
murine TNF (2.5µg/kg body weight) or D-Gal alone. The animals were observed 
during the next 36 hr, after which no further deaths occurred. The survival rate clearly 
showed that Pellino3 knockout mice were much more sensitive to TNF/D-Gal 
compared with their WT counterparts (Figure 3-44 A). 5 of 11 (45%) Pellino3 
knockout mice died in 12 hr after being challenged, while all remaining knockout mice 
died within 24 hr. The administration of D-gal alone had no affect on the survival of 
Pellino3
+/+ 
or Pellino3
-/- 
mice (Figure 3-44 B).  
Given that hepatoxicity is the key contributing factor to the lethal effects in this model, 
liver tissue was examined from the different mouse cohorts. Indeed, the livers of 
Pellino3 knockout mice after TNF/D-Gal challenge displayed widespread hemorrhage 
whereas no such effects were apparent in Pellino3-deficient that had not been 
challenged with TNF or in wild type control mice irrespective of the administration 
regime (Figure 3-45). 
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Co-administration of D-Gal and TNF to Pellino3
+/+ 
mice lead to widespread swelling 
of hepatocytes due to microvesicular vacuolation and fine granulation of the cytoplasm 
leading to compression of sinus structures. This is typical of an adaptive cell response 
to injury coupled with proliferation of hepatic drug metabolizing enzymes as a result of 
D-gal treatment. In contrast, the same co-administration protocol in Pellino3
-/- 
mice led 
to widspread hepatotoxicity with marked disruption of hepatocyte cord structures and 
part replacement by red blood cells. Individual hepatocytes were swollen with many 
cells containing karyorrhectic (fragmented) nuclei. Immunohistologic analysis of the 
activation of caspase-3 using an antibody that recognizes only the active caspase-3 p17 
subunit was performed to evaluate the apoptosis induced by TNF/D-Gal. TNF/D-gal 
induced massive caspase-3 activation in Pellino3 knockout liver but only a few in the 
wild-type counterparts (Figure 3-46). In support of these immunohistochemistry data, 
Western immunoblot revealed a significant activation of caspase-8 and caspase-3 in 
the Pellino3
–/–
 livers at 12 hr after TNF/D-Gal injection (Figure 3-47). These data 
provide very strong evidence for a critical physiological role for Pellino3 in regulating 
the potential toxic effects of TNF. 
Cytokines are potential effector molecules that modulate and regulate immune 
responses (Strieter et al., 1996). During inflammatory responses, IL-6 is produced to 
regulate the development of Th 17 cells and the acute phase response (Yoshimura et al., 
2009). IL-10 regulates differentiation and proliferation of multiple immune cells 
(Asadullah et al., 2003). RANTES is chemotactic for T cells, eosinophils, and 
basophils and plays an active role in recruiting leukocytes into inflammatory sites 
(Taub et al., 1996). TNF regulates leukocyte activation and infiltration, macrophage 
activation and triggering T-lymphocyte responses within tissues (Jap and Chee, 2008). 
To investigate the role of the immune response in TNF/D-Gal-induced apoptosis, the 
levels of IL-6 (Figure 3-48A), IL-10 (Figure 3-48B), RANTES (Figure 3-48C) and 
TNF (Figure 3-48D) cytokines were measured by ELISA. TNF/D-Gal caused only 
very modest increases in serum concentrations of all of the cytokines in Pellino3 
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knockout mice compared with wild type mice. There was no statistically significant 
difference found. Thus the death caused by TNF/D-Gal exposure in Pellino3 knockout 
mice is not due to the excessive and uncontrolled production of inflammatory 
mediators and pro-inflammatory cytokines. 
In conjunction with the earlier cell-based approaches these in vivo findings now 
provide unequivocal support for Pellino3 acting as a novel player in TNF biology. The 
high sensitivity of Pellino3
-/- 
mice to the lethal effects of TNF clearly promotes 
Pellino3 as a crucial factor in determining whether cells survive or die in response to 
TNF challenge. 
 
Figure 3-44 Loss of Pellino3 in mice leads to increased hepatoxicity and lethality in response to in 
vivo administration of TNF. 
Age- and sex-matched Pellino3+/+ and Pellino3-/- mice were injected intraperitoneally with 2.5 µg TNF plus 0.8g D-
Gal per kg body weight (n=11) or D-Gal alone (n=5). Survival was monitored every hour for 36 hr. (A) Survival 
curves of mice injected with TNF plus D-Gal. (B) Survival curves of mice injected with D-Gal alone. 
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Figure 3-45 Liver tissues after injection of TNF and D-Gal 
Age- and sex-matched Pellino3+/+ and Pellino3-/- mice were injected intraperitoneally with 2.5µg TNF plus 0.8g D-
Gal per kg body weight or D-Gal alone. Liver tissues were collected and photographed at 12 hr after injection. 
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Figure 3-46 Loss of Pellino3 sensitizes liver cells to TNF/ D-Gal-induced apoptosis  
Age- and sex-matched Pellino3+/+ and Pellino3-/- mice were injected intraperitoneally with TNF and D-Gal or D-Gal 
alone. Hepatic tissue was collected 12 hr after injection, sectioned and subjected to histological analysis using 
Haematoxylin and eosin (H&E) staining and immunohistochemistry using anti-cleaved caspase-3 antibody. (bar 
20μm).The white arrows indicate cells with fragmented nuclei.  
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Figure 3-47 Pellino3 deficiency leads to increased apoptotic markers in hepatic tissue in response to 
TNF/ D-Gal 
Age- and sex-matched Pellino3+/+ and Pellino3-/- mice were injected intraperitoneally with TNF and D-Gal or D-Gal 
alone. Cell lysates were generated from hepatic tissue 12 hr post injection and probed by immunoblotting for levels 
of cleaved caspase-3, caspase-8, mPellino3 and β-actin. 
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Figure 3-48 Proinflammatory cytokine levels after TNF/Gal injection. 
Age- and sex-matched Pellino3+/+ and Pellino3-/- mice were injected intraperitoneally with TNF and D-Gal or D-Gal 
alone. Blood samples are taken from mice 7 hr after injection and serum assayed by ELISA or levels of IL-6 (A), 
IL-10 (B), Rantes (C) and TNF (D) . Data represent the mean +/- S.D. of 4 independent experiments.  
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CHAPTER FOUR: DISCUSSION 
TNF is a proinflammatory cytokine that regulates multiple cellular processes, such as 
apoptosis, proliferation and inflammation (Wajant et al., 2003). Inappropriate 
production of TNF or sustained activation of TNF signalling has been correlated to 
the pathogenesis of many human diseases, including cancer, sepsis, diabetes and 
autoimmune diseases (Aggarwal, 2003). Understanding the signal transduction 
mechanisms involved in regulating the TNF pathway has created opportunities in 
identifying novel targets, which may be useful in therapeutic treating inflammatory 
disorders. The aim of this study was to investigate the potential role of Pellino3 in the 
regulation of the TNF signalling. 
4.1 Pellino3 is a key regulator of TNF-induced apoptosis 
While using a siRNA or shRNA-based targeting strategy to suppress the endogenous 
expression of Pellino3, a significant increase in sensitivity to TNF-induced cell death 
was observed in various cell lines, including Hela, HEK293T, 1321N1 and U373. In 
order to define the physiological relevance of the role of Pellino3 in TNF signalling, 
Pellino3-deficient mice were generated. Consistent with observations obtained from 
human cell lines, cells from Pellino3-deficient mice are much more sensitive to TNF-
induced apoptosis, compared to their wild type control cells, demonstrating that the 
role for Pellino3 in regulating TNF-induced cell death is not a cell line-specific 
phenomenon. Instead Pellino3 appears to play a widespread role in regulating cell 
survival in response to TNF. Although TNF has been identified as a potent inducer of 
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apoptotic cell death, it has also been shown to contribute to necrosis (Denecker et al., 
2001; Fiers et al., 1995). However Pellino3 seems to regulate the pro-apoptotic effects 
of TNF based on the use of apoptotic markers. Thus knockdown or deficiency in 
Pellino3 expression lead to increased Annexin V staining, a key signatute of apoptosis.  
Furthermore, this event could be efficiently blocked by the pan-caspase inhibitor 
zVAD-fmk, indicating that TNF induced a caspase-dependent apoptosis in Pellino3 
deficient cells. In addition, during apoptosis, members of the caspase protease family 
are activated, leading cells to undergo rapid death (Kumar, 1995; Yuan et al., 1993). 
Cleaved caspase-8, cleaved caspase-3 and PARP are typical  markers for the detection 
of apoptotic cells (Muzio et al., 1996; Tewari et al., 1995; Margolin et al., 1997). In 
this study, cleavage of caspase-3, caspase-8 and PARP were also measured to confirm 
that apoptosis was occurring, and in keeping with the other markers of apoptosis, 
Pellino3 deficiency resulted in increased levels of cleaved forms of these proteins in 
response to TNF. 
In order to ensure that the greater pro-apoptotic effects of TNF in Pellino3
 
knockdown 
or knockout cells were due specifically to Pellino3 deficiency, rescue experiments 
were performed. Introduction of the expression construct encoding Pellino3s or 
Pellino3l could efficiently prevent the TNF-induced apoptosis in Pellino3 deficiency 
HEK293T cells. This was demonstrated by reduced  Annexin V staining and cleavage 
of PARP and caspase-3, indicating that both spliced forms can temper the pro-
apoptotic signalling of TNF. Moreover, a murine Pellino3 expression construct also 
rescued Pellino3
-/-
 deficient MEFs from undergoing apoptosis in response to TNF 
stimulation.  
Based on these various approaches spanning cell lines to genetic models this study 
provides very strong support for a key role for Pellino3 in regulating TNF-induced 
apoptosis. 
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4.2 The regulatory effects of Pellino3 in apoptosis are not due to 
modulation of the NF-κB/ MAPK pathways  
In most cell types, aberrant TNF signalling tend to activate the oncogenic and pro-
inflammatory signalling pathways, such as NF-κB and MAPKs which exert positive 
effects on cell survival and proliferation rather than triggering apoptosis 
(Varfolomeev et al., 1996). Most cell types are resistant to apoptosis induced by TNF, 
unless the cells are treated with a sensitising agent, such as protein synthesis inhibitor, 
cycloheximide (CHX). This results in the disruption in the balance between cell 
survival and death  and instructs cells to undergo apoptosis (Vassalli, 1992). This is 
mainly due to blockade of induction of NF-κB responsive anti-apoptotic genes. Given 
the key counter-regulatory role of NF-κB in controlling the apoptotic arm of the TNF 
signalling pathway it was essential to explore if the effects of Pellino3 deficiency on 
TNF-induced apoptois could have an underlying basis in dysregulation of the NF-κB 
pathway. This was especially relevant in the context of an increasing literature 
exploring the regulatory importance of the Pellino family in the NF-κB pathway.  
Published transfection studies with cell-line models suggest that Pellino1 and Pellino2 
have the ability to activate NF-κB in IL-1 signalling (Jiang et al., 2003; Yu et al., 
2002). However, the suggestion that Pellino1 plays a positive role on NF-κB 
activation in response to IL-1 has been challenged with findings from Pellino1 
deficient mice. A study on Pellino1
–/–
 MEFs showed that the genetic deficiency of 
Pellino1 had no effect on the ability of IL-1 to promote activation of NF-κB (Chang et 
al., 2009). However the latter study also demonstrated that deficiency in Pellino1 
attenuated the activation of NF-κB in MEFs and splenocytes in response to TLR3 and 
TLR4 stimulation. A mechanistic explanation was provided by Pellino1 acting as a 
ubiquitin E3 ligase for RIP1 thus catalysing ubiquitination of the latter and facilitating 
TRIF-dependent TLR3/4-induced activation of NF-κB. This demonstrates that the 
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function of Pellino1 in terms of regulating activation of NF-κB may be stimulus 
dependent. Indeed Pellino1 has been recently shown to inhibit T cell activation by 
negatively regulating the NF-κB subunit c-Rel (Chang et al., 2011). In the latter study 
Pellino1 was shown to ubiquitnate c-Rel thus promoting its degradation and 
downregulating T cell activation, a key part of the tolerance to self antigens. This 
raises the intriguing contrast of Pellino1 acting to positively regulate NF-κB 
activation in the TLR3/4 pathways whereas it negatively regulates  the activation of 
NF-κB by CD28/T cell receptor co-stimulation in T cells (Moynagh, 2011). 
Interestingly a report has also suggested that Pellino3 may play a negative regulatory 
role with respect to NF-κB (Xiao et al., 2008). Using cell line models the authors  
propose that Pellino3 inhibits IL-1-induced activation of NF-κB by catalysing  K63-
linked IRAK polyubiquitylation and this competes with K48-linked IRAK 
polyubiquitylation for the same ubiquitylation site, Lys134 and blocks IRAK 
degradation. Xiao et al propose that degradation of IRAK is required for NF-κB 
activation but this model lacks some clarity (Moynagh, 2009). Indeed various reports 
question the importance of IRAK-degradation in the NF-κB pathway especially given 
the findings that the polyubiquitination of Lys134 on IRAK is not essential for IL-1 
signalling (Conze et al., 2008; Windheim et al., 2008).  
Whilst the role of Pellino1 in TNF signalling was not explored in Pellino1-deficient 
mice (Chang et al., 2009), earlier studies using gene knockdown technology in cell 
lines reported that Pellino1 and Pellino2 fail to play a role in TNF-induced activation 
of NF-κB (Jiang et al., 2003; Yu et al., 2002). However until the present study the role 
of Pellino3 in regulating TNF-induced activation of NF-κB activation had not been  
explored and we were also keen to examine its potential role in this pathway as a 
means to explain its modulatory effects on TNF-induced apoptosis.  
The activation of NF-κB is dependent on the phosphorylation and degradation of its 
inhibitory IκB proteins. The phosphorylation of the IκB is initiated through the IKK 
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complex, which consist of two catalytic subunits IKKα and IKKβ and the regulatory 
subunit IKKγ (DiDonato et al., 1997; Mercurio et al., 1997; Regnier et al., 1997). In 
this study, the deficiency of Pellino3 increased TNF-induced NF-κB signalling events, 
including phosphorylation of IKKα/β, phosphorylation of IκBα and degradation of 
IκBα. Moreover, EMSA data obtained direct evidence that Pellino3 negatively 
regulated NF-κB activation in TNF signalling pathway. This is consistent with a 
previous report indicating that Pellino3 may negatively regulate IL-1 induced 
activation of NF-κB (Xiao et al., 2008).  Since NF-κB tends to be regarded as a pro-
survival transcription factor, the increased activation of NF-κB in response to TNF 
under conditions of Pellino3 deficiency or knockdown, tends to exclude a role for NF-
κB in mediating the pro-apoptotic effects following suppressed Pellino3 expression.  
Although Pellino1 has no effect on any of the MAPK pathways and Pellino2 drives 
activation of the ERK1/2 and JNK pathways, Pellino3 has been shown to have the 
ability to promote the activation of p38 MAPK, which induces cell death in some cell 
lines (Butler et al., 2005; Jensen and Whitehead, 2003a). Similar to the positive role 
for Pellino3 in mediating IL-1 –induced activation of p38 MAPK (Butler et al., 2005), 
the present findings also suggest a mediatory role for Pellino3 in facilitating TNF-
induced activation of p38 MAPK and  JNK. Since p38 and JNK activity is thought to 
promote apoptosis (Horstmann et al., 1998; Tang et al., 2001), the decreased 
phosphorylation levels of p38 and JNK that were observed in response to TNF in 
Pellino3 deficient cells  argues against a role for these MAPK pathways in mediating 
the pro-apoptotic effects associated with Pellino3 deficiency. 
Moreover, expression of several anti-apoptotic proteins associated with NF-κB or 
MAPK pathway were also tested at the mRNA and protein levels. Elevated mRNA 
levels of A20 and cFLIP were observed in response to TNF treatment and such 
expression was not compromised in the absence of Pellino3 and this is consistent with 
the strong activation of NF-κB under these conditions. The lack of a role for the NF-
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κB pathway in underlying the pro-apoptotic effects of TNF under conditions of low or 
absent Pellino3 expression argued for an analysis of a direct role for Pellino3 in 
regulating the apoptotic arm of the TNF pathway.   
4.3 Pellino3 is a regulator of DISC formation 
Upon TNF stimuli, TNFR trimerisates and recruits many effector proteins, such as 
TRADD, TRAF2, TRAF5 and RIP1 to form a complex referred as complex I (Chen 
and Goeddel, 2002). RIP1 is a key in determining the cells‟ fate to live or die. RIP1 
can activate NF-κB by recruiting the IKK complex to TNF-R1, which is dependent on 
the TNF-induced K63-linked polyubiquitin of RIP1, thus facilitating the recruitment 
of the IKK complex (Meylan et al., 2004; Ting et al., 1996; Ea et al., 2006). RIP1 can 
also recruit FADD via a homotypic DD-DD interaction, forming a new complex, 
named complex II. The new complex subsequently activates procaspase-8 and 
initiates cell apoptosis. Given that Pellino3 has anti-apoptotic activity, and Pellino1 
has showed its ability to interact with and ubiquitinate RIP1 (Chang et al., 2009), 
which is a key component of DISC, it was conceivable that Pellino3 may affect the 
formation of DISC. The interactions between Pellino3 and the core components of 
DISC, RIP1, FADD and caspase-8 were also examined. Pellino3 and RIP1 indeed 
formed a stable complex, which was detected by coimmunoprecipitation assay. In 
vitro binding assays also showed that Pellino3 bound directly to RIP1. Interestingly, 
Pellino3 does not affect RIP1 ubiquitination (data not shown), and this contrasts with 
the ability of  Pellino1 to act as an ubiquitin E3 ligase for RIP1 (Chang et al., 2009). 
This demonstrates the non-redundant nature of members of the Pellino family. 
 Coimmunoprecipitation assays and in vitro binding assays also showed that Pellino3 
directly interacts with caspase-8. Procaspase-8 contains a C-terminal catalytic domain 
and two DEDs in its N-terminal, which interact with a homologous DED on FADD 
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(Cryns and Yuan, 1998). After complex II formation, caspase-8 is slowly activated. 
While the catalytic domain of caspase-8 stays in the complex, the active p20/p18 
domain is released to cytosol (Jin and El-Deiry, 2006). Our studies show that Pellino3 
interacts with the catalytic domain of caspase-8, not the DED domain, indicating that 
after Caspase-8 activation Pellino3 may still stay in the complex and play a further 
role. Moreover, Pellino3 does not bind to FADD. The ability of Pellino3 to interact 
with endogenous RIP1, procaspase-8 and FADD in the presence of TNF were also 
assessed. Overexpressed Pellino3 is constitutively associated with procaspase-8, and 
after TNF stimulation Pellino3 is recruited to RIP1, and thus brings the latter into 
close proximity with procaspase-8. Pellino3 has no interaction with endogenous 
FADD, which is consistent with the coimmunoprecipitation results. However, the 
suppressed expression of Pellino3 resulted in greater levels of RIP1 and FADD 
interacting with caspase-8 and as such the increased DISC formation is consistent 
with the greater pro-apoptotic effects of TNF in cells where Pellino3 expression is 
suppressed. Collectively, these data demonstrate that Pellino3 plays a key role in 
regulating DISC formation and apoptosis in response to TNF. 
Recent studies have reported that A20 binding and inhibitor of NF-κB (ABIN-1) and 
ubiquitously expressed transcript-V1 (UXT-V1) have the ability to protect cells 
against TNF-induced apoptosis. ABIN-1 functions through inhibiting caspase-8 
recruitment to FADD, preventing caspase-8 cleavage and programmed cell death 
(Oshima et al., 2009). UXT-V1 plays its role by binding to TRAF2 and preventing the 
TRAF2-RIP-TRADD complex from recruiting FADD and caspase-8 (Huang et al., 
2011). Pellino3 may work through a mechanism that is similar to that used by ABIN-
1. However, ABIN-1‟s anti-apoptotic activity requires its ubiquitin sensing activity 
(Oshima et al., 2009). Although Pellino3 contains a RING like motif and possess E3 
ubiquitin ligase activity (Butler et al., 2007), the present study shows that regulatory 
effects of Pellino3 in the TNF pathway are not dependent on its E3 ligase activity.   
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4.4 Pellino3 targets RIP1 in a FHA domain-dependent manner 
All Pellino proteins contain a C-terminal RING-like domain and an N-terminal FHA 
domain. The first functional motif identified in Pellino proteins was the RING-like 
domain. Proteins containing RING domains possess a ubiquitin ligase activity that 
catalyses the transfer of ubiquitin chains from E2 ubiquitin conjugating enzymes to 
the target substrates (Deshaies and Joazeiro, 2009). Pellino proteins have been shown 
to have both K63 and K48 E3 ligase activities. They interact with IRAK with the 
latter being capable of inducing phosphorylaton  and increasing the E3 ligase activity 
of the Pellinos ultimately resulting in increased polyubiquitination of IRAK (Butler et 
al., 2007; Ordureau et al., 2008). RIP1 acts in an equivalent capacity to IRAK-1 in the 
TNF pathway and thus it was intriguing that Pellino1 can also bind and ubiquitinate 
RIP1. However our study shows no evidence that Pellino3 is involved in regulating 
RIP1 ubiquitination. Also the RING mutant of Pellino3 was still able to interact with 
RIP1 (in related research of this study), suggesting the regulatory effects of Pellino3 
on DISC formation and apoptosis are independent of its E3 catalytic activity. The 
FHA domain is a phosphopeptide recognition domain, found in many regulatory 
proteins which play a role in the checkpoint and DNA-damage response (Durocher et 
al., 2000). Lin et al. discovered that Pellino2 binds to the phosphorylated forms of 
IRAK through their FHA domain and targets them for ubiquitinylation (Lin et al., 
2008). As RIP1 is a distant relative to the IRAK family (Dardick and Ronald, 2006) 
and upon TNF treatment, RIP1 undergoes autophosphorylation and ubiquitination 
(Lee et al., 2004), this suggested that the FHA domain might play a role in RIP1-
Pellino3 interaction. Coimmunoprecipitation assays and in vitro binding assays 
showed that the FHA domain of Pellino3 is required for its binding to RIP1.  
Furthermore, the FHA domain of Pellino3 is crucial for its anti-apoptotic activity. 
This at least demonstrates a critical role for the FHA domain in Pellino3 biology. 
However the questions remains as to the functional relevance of the RING-like 
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domain of Pellino3. Given its highly conserved nature and preservation through 
evolution it is likely to be of fundamental importance but it remains to be delineated.  
4.5 In vivo animal studies 
As mentioned in 4.1, Pellino3-deficient mice were generated to further investigate the 
function of Pellino3 in vivo. The Pellino3 homozygous knockout mice were viable, 
and their general condition did not reveal gross abnormalities with the exception of a 
reduced body weight. The proportions for heterozygous and homozygous mutant pups 
are slightly lower than the expected Mendelian ratio. Foetal loss of Pellino3 mutant 
mice suggests that Pellino3 may play a role in embryo development or fertilization 
and it is interesting to speculate that this may be related to the increased propensity of 
cells to undergo apoptosis when Pellino3 expression is reduced or absent.  
Furthermore, Pellino3-deficient mice showed a greatly increased susceptibility to the 
lethal effects of TNF and this was associated with increased severity of TNF-induced 
hepatotoxicity. This finding provides strong physiological evidence to support the 
previous in vitro studies that loss of Pellino3 greatly increases the proclivity of TNF 
to induce apoptosis. 
4.6 Concluding Remarks 
In summary, the present findings highlight Pellino3 as a new player in the TNF 
signalling pathway, and strongly indicate that it may play an important role in 
determining whether a cell survives or dies in response to TNF. Pellino3 directly 
interacts with the DISC components, RIP1 and caspase-8. Knockdown or genetic 
deficiency of Pellino3 sensitises cells to TNF-induced apoptosis, which is 
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independent of NF-κB or MAPK signalling. Instead the loss of Pellino3 leads to 
increased DISC formation in response to TNF. Interestingly, the regulatory effects of 
Pellino3 on RIP1 are independent of its well-known E3 ligase activity. Instead the N- 
terminal FHA domain of Pellino3 is crucially important in facilitating its interaction 
with RIP1 and the regulation of TNF-induced DISC formation. The FHA domain is a 
phosphothreonine-binding module, and the identification of potential recognition sites 
on RIP1 for the FHA domain of Pellino3 will add greatly to our understanding of the 
TNF signalling pathway. Pellino3-deficient mice also show a greatly increased 
sensitivity to TNF-induced hepatotoxicity and ultimate lethality, thus emphasising the 
crucial physiological role of Pellino3 in determining cell‟s fate in response TNF 
challenge. 
The role of Pellino3 in the regulation of the formation of FADD-RIP1-caspase-8 
complexes independently of death receptor signalling may also be interesting to 
explore. Recent reports described a cytosolic death-inducing FADD-caspase-8-RIP1 
complex that forms independently of death receptor activation but in response to 
intracellular stress (Feoktistova et al., 2011; Tenev et al., 2011). To differentiate it 
from complex II, the “Ripoptosome” was coined to define a complex that forms 
spontaneously in response to depletion of cIAPs by IAP antagonists or the genotoxic 
compound etoposide. It will be interesting to explore the potential of Pellino3 to 
regulate Ripoptosome formation and cell death pathways in response to such 
intracellular cues and stress. The role of Pellino3 during TNF-induced apoptosis is 
presented in Figure 4-1. 
The present study also adds to a growing appreciation of the diverse functions of the 
Pellino family in immune signalling pathways. To date most studies focused on 
Pellino proteins as regulators of IL-1 and TLR signalling, this study extends their 
roles beyond these pathways. Interestingly a very recent report has described  Pellino1 
as an important regulator of T cell activation and self tolerance (Chang et al., 2011). 
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Such findings, in conjunction with the present study, add to an increasing appreciation 
of the importance of the Pellino family in a variety of signalling pathways in the 
innate and adaptive immune systems. 
 
Figure 4-1 The role of Pellino3 during TNF-induced apoptosis. 
Pellino3 blocks recruitment of FADD in the DISC. Pellino3 directly interacts with the DISC components, RIP1 
and caspase-8. The FHA domain of Pellino3 is crucial in facilitating its interaction with RIP1 and the regulation of 
TNF-induced DISC formation. The loss of Pellino3 leads to increased DISC formation in response to TNF.  
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APPENDIX  
Appendix I: 
PrimerName Primersequence(5‟-3‟) Application 
HA-c8as ATTGCGGCCGCTCAATCAGAAGGGAAGACAAGTTTTTTTC HA-caspase-8 
HA-c8s CTGGTCGACCATGGACTTCAGCAGAAATCTTTATG  
P4-c8DEDs CTGGATATCACCATGGACTTCAGCAGAAATCTTTATG Myc- caspase-8 DED 
P4-c8DEDas ATTCTCGAGATCAGGACTTCCTTCAAGGCTGCTG  
PET-c8DEDs CTGGATATCATGGACTTCAGCAGAAATCTTTATG 6 x his- caspase-8DED 
PET-c8DEDas ATTCTCGAGTATCAGGACTTCCTTCAAGGCTGCTG  
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P4-c8DDEDs CTGGATATCACCATGGAATTTTCAAATGGGGAGGAGTTG Myc- caspase-8DDED 
p4-C8DDEDas ATTGCGGCCGCCAATCAGAAGGGAAGACAAGTTTTTTTC  
PRSET-C8bFLs CTGGGATCCATGGACTTCAGCAGAAATCTTTATG 6 x his- caspase-8 full length 
PRSET-C8bFLas ATTAAGCTTCGATCAGAAGGGAAGACAAGTTTTTTTC  
PET-c8DDEDs CTGGATATCGAATTTTCAAATGGGGAGGAGTTG 6 x his caspase-8DDED 
PET-c8DDEDas ATTGCGGCCGCAATCAGAAGGGAAGACAAGTTTTTTTC  
Retro-mP3s CTGCTCGAGGCGATGGTGCTGGAAGGAAAC C Retro-murine Pellino3 
Retro-mP3as ATTGTCGACCTACAGATCTTCTTCAGAAATAAGTTTTTGTTC  
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Table I Primers for PCR amplification, cloning 
PrimerName Primersequence(5‟-3‟) Application 
mHPRTs GTCCCAGCGTCGTGATTAGC murine HPRT 
mHPRTas TGGCCTCCCATCTCCTTCA  
mA20s  TGCCAGTTTTGCCCACAGT murine A20 
mA20as TTCAGAGCCACGAGCTTCCT   
cFLIPs  GCTCCAGAATGGGCGAAGT murine cFLIP (both isoforms) 
cFLIPas CACGGATGTGCGGAGGTAA   
mP3t2s ACATGCCAACGGAGTGAAGC murine Pelino3 (both isoforms) 
mP3t2as AGCGGCCAATCTGGAACAT  
Table II Primers for mRNA relative quatification 
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Appenix II: Vectors and plasmids 
 
Figure I Maps of pRSET A 
Adapted from http://products.invitrogen.com/ivgn/product/V35120 
Appendix 
 
165 
 
Figure II Maps of pET-30a 
Adapted from  
http://aether.sgc.ox.ac.uk:2784/structures/MM/Vectors/pET30a/pET30a_vector_sheet
.pdf 
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Figure III  Maps of pCMV-HA Vector 
Adapted from 
 http://www.clontech.com/IE/Products/Protein_Interactions_and_Profiling/Co-
immunoprecipitation/Myc-Tagged_and_HA-Tagged_Vectors?sitex=10023:22372:US 
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Figure IV Maps of pMSCV vectors. 
Adapted from http://tools.invitrogen.com/content/sfs/vectors/pcdna4tomychis.pdf 
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Figure V Maps of pMSCV vectors. 
Adapted from  
http://www.clontech.com/IE/Products/Viral_Transduction/Retroviral_Vector_System
s/MSCV?sitex=10023:22372:US 
 
 
